The Role of Exonuclease-1 and its Interaction Partners in Genome Stability by Eid, Wassim
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2011
The Role of Exonuclease-1 and its Interaction Partners in Genome Stability
Eid, Wassim
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-65281
Originally published at:
Eid, Wassim. The Role of Exonuclease-1 and its Interaction Partners in Genome Stability. 2011, Uni-
versity of Zurich, Faculty of Science.
 
 
 
 
The Role of Exonuclease-1 and its Interaction 
Partners in Genome Stability 
 
 
 
Dissertation 
zur 
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.) 
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät 
der 
Universität Zürich 
von 
 
Wassim Eid 
 
aus 
Ägypten 
 
Promotionskomitee 
Prof. Dr. Alessandro Sartori 
PD Dr. Stefano Ferrari (Leitung der Dissertation) 
Prof. Dr. Claus Azzalin 
Prof. Dr. Martin Scheffner 
 
Zürich, 2012 
  2 
 
 
 
 
 
 
 
 
 
 
 
-to Malika- 
 
I was lucky to meet you before you left us forever 
 
You will always be missed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index 
 
 
  3 
SUMMARY 
 
ZUSAMMENFASSUNG 
 
1.INTRODUCTION 
 
 
1.1.     DNA damage, genomic instability and cancer 
1.2.     The DNA damage response 
1.3.     DNA double-strand breaks 
1.3.1   Double-strand break signaling   
1.3.2.  Ionizing radiation-induced foci formation 
1.4.    The DNA damage checkpoints 
1.4.1. The G1/S checkpoint 
1.4.2. The S-phase checkpoint 
1.4.3. The G2 checkpoint 
1.5.    DNA double-strand break repair 
1.5.1. Non-homologous end-joining 
1.5.2. Homologous recombination  
1.6.    DNA nucleases 
1.6.1. General features of DNA nucleases 
1.6.2. Exonuclease 1 (EXO1) 
1.6.3. CtBP-interacting protein (CtIP) 
 
2. RESULTS 
 
2.1. DNA end resection by CtIP and Exonuclease 1 prevents genomic 
instability 
2.2.   Refining the interaction domain between EXO1 and CtIP 
2.3.  Identification and functional evaluation of novel interacting partners of 
EXO1 
 
2.3.1. Cloning Strep-tagged EXO1 and validating the system 
 
2.3.2. Large scale Strep-tagged EXO1 pull-down 
2.3.3. First mass spectrometry 
2.3.4. Second mass spectrometry  
 
Index 
 
 
  4 
3. DISCUSSION 
 
4. MATERIALS AND METHODS 
 
5. REFERENCES  
 
 
6. ABBREVIATIONS  
 
 
7. CURRICULUM VITAE 
 
 
8. ACKNOWLEDGMENTS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary 
 
 
5 
Summary  
 
Cells are constantly under the assault of endogenous and exogenous forms of 
damage that threaten genome integrity. Maintaining a complete, undamaged 
genome is a continual challenge and it is of vital importance to the cell and its 
progeny. To accomplish this, eukaryotes have evolved a complex signal 
transduction pathway that senses DNA lesions and triggers DNA repair. This 
complex signaling network is collectively known as the DNA damage 
response (DDR). Double strand breaks (DSBs) are the most cytotoxic DNA 
lesions. Unrepaired DSBs, or their misrepair, can cause gross chromosomal 
aberrations that may trigger carcinogenesis through activation of oncogenes 
or inactivation of tumour suppressor genes. Cells employ two main 
mechanisms to repair DSBs: non-homologous end-joining (NHEJ) and 
homologous recombination (HR). NHEJ takes place throughout the cell cycle, 
whereas HR is restricted to the S/G2 phases. Both in yeast and human cells 
HR is initiated by 5’-3’ resection of DNA ends. This occurs in two-steps, with 
initial DNA “end-trimming” by the MRN complex and CtIP in human cells, 
followed by more extensive resection executed by EXO1 or BLM and DNA2. 
In the first part of this study we investigated the molecular mechanism of the 
early step of DNA resection. We show that EXO1 is recruited to laser-induced 
DSBs in a CtIP and MRN dependent manner. We also show that EXO1 
physically interacts with CtIP both in vivo and in vitro and, interestingly, this 
interaction restrains the exonucleolytic activity of EXO1 in vitro. We suggest 
that restraining EXO1 activity in vivo could prevent the formation of 
excessively long recombination intermediates that may hamper the faithful 
execution of HR. Accordingly, we provide evidence that CtIP and EXO1 act 
together to oppose NHEJ and promote the error-free repair of DSBs through 
HR, hence maintaining genome stability.  
In the second part of this study we set out to identify proteins interacting with 
EXO1 in order to better understand the role and the regulation of EXO1 in 
DNA-end resection. In a large-scale mass spectrometry analysis, we 
successfully identified novel EXO1 interacting proteins that could have a 
potential role in DNA repair and that we are currently evaluating. 
Zusammenfassung 
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Zusammenfassung 
 
Zellen sind konstant endogenen und exogenen Formen von DNS Schäden 
ausgesetzt die die Integrität des Genomes gefährden. Das Erbgut komplett 
und ungeschädigt zu erhalten, ist essentiell für die Zelle. Eukaryonten haben 
dafür einen komplexen Signaltransduktionsweg entwickelt, welcher Schäden 
erkennt und anschliessend die Reparatur derselben erlaubt. Dieses Netzwerk 
der DNS Reparatur ist als DNS-damage response bekannt. DNS 
Doppelstrangbrüche (DSBs) sind die am zytotoxischsten Erbgutschäden und 
unvollständige oder falsche Reparatur kann Chromosomenschäden 
verursachen. Diese können durch Aktivierung von Onkogenen oder 
Deaktivierung von Onkosuppressoren schlussendlich eine Zelltransformation 
hervorrufen und Krebs verursachen. Die Hauptformen der DNS 
Doppelstrangbruchreparatur sind non homologous end-joining (NHEJ) und 
homologe Rekombination (HR). NHEJ ist während des ganzen Zellzyklus 
aktiv, HR nur in der S-und der G2 Phase. Homologe Rekombination beginnt 
mit einer 5'-3' DNS Resektion, ein konservierter Mechanismus der sowohl in 
Hefe- als auch in menschlichen Zellen stattfindet. Die Resektion findet in zwei 
Schritten statt. Anfangs arbeiten der MRN-Komplex und CtIP zusammen um 
einige wenige Nukleotide des Doppelstrangbruches zu prozessieren. Die 
Resektion wird durch EXO1 und/oder BLM und DNA2 in einem zweiten Schritt 
vervollständigt.  
Im ersten Teil dieser Studie haben wir die molekularen Mechanismen der 
DNS Resektion untersucht. Wir zeigen, dass EXO1 zu laser-induzierten DSBs 
rekrutiert wird und die Rekrutierung von MRN und von CtIP abhängig ist. 
Weiters konnten wir zeigen, dass CtIP und EXO1 in vitro und in vivo 
interagieren und CtIP die Aktivität der Exonuklease EXO1 in vitro hemmt. Wir 
schlagen ein Modell vor, in dem CtIP die Aktivität von EXO1 in vivo 
einschränkt und somit die exessive Formation von einzelstraengiger DNS 
verhindert. Übermäβige DNS Resektion könnte den normalen HR Ablauf 
beeinträchtigen. Dementsprechend zeigen wir, dass CtIP und EXO1 
zusammenarbeiten um NHEJ zu verhindern und die Reparatur der DSBs 
durch HR begünstigen. Somit wird die Stabilität des Genomes 
aufrechterhalten.  
Zusammenfassung 
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Der zweite Teil unserer Studie ist der Identifikation von Interaktionspartnern 
von EXO1 gewidmet. In einem auf Massenspektrometrie basierenden Screen 
konnten wir bisher unbekannte Interaktionspartner von EXO1 identifizieren die 
potentiell eine wichtige Rolle in der DNS Reparatur haben könnten. 
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1.INTRODUCTION 
 
1.1. DNA damage, genomic instability and cancer 
The human genome is subject to constant damage induced by environmental 
agents (exogenous) or generated spontaneously during normal cellular 
processes (endogenous). Exogenous sources of DNA damage can be of 
physical or chemical type. Examples of physical genotoxic agents are 
ultraviolet (UV) radiation from sunlight and ionizing radiation (IR) from medical 
imaging and treatments employing X-rays. Chemical agents used in cancer 
therapy, such as cisplatin or etoposide can also cause different types of DNA 
lesions. Furthermore, DNA damage can be the result of endogenous 
metabolic processes producing reactive oxygen species (ROS) or may arise 
from inaccurate DNA replication. DNA lesions generated from these sources 
represent a constant threat to genome stability. 
DNA repair and maintenance of a stable genome are crucial to cellular and 
organismal function. This is illustrated by the fact that deficiencies or 
abnormalities in DNA repair pathways lead to several pathological conditions. 
Mutations in DNA repair genes have been implicated in the development of 
neurological diseases and aging, in increased risk of cancer development, in 
less favorable cancer therapy outcomes, in inflammation and in a number of 
genetic syndromes that often show a cancer-prone phenotype, such as 
Ataxia-telangiectasia (A-T), Nijmegen breakage syndrome (NBS) or Fanconi 
Anemia (FA) (Ciccia and Elledge, 2010). 
To counteract DNA damage and to maintain genome integrity, cells need to 
adequately respond to various types of genotoxic stress. This is achieved by 
activation of evolutionary conserved DNA-damage response (DDR) pathways 
that results in a two-pronged effect: a block in cell cycle progression and the 
concomitant induction of DNA repair. Depending on the extent of damage 
suffered by DNA, cells may repair all lesions and re-enter the cell cycle, a 
condition known as checkpoint recovery or, in the case of excessive damage, 
be eliminated by programmed cell death (apoptosis). Alternatively, cells 
undergo an apparently permanent arrest after DNA damage. This state is 
known as "replicative senescence" and consists of an irreversible growth-
Introduction 
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arrest program that prevents unlimited cell proliferation. Although senescent 
cells in vitro may remain indefinitely viable, this may not be the case in vivo 
(Collado et al. 2007). Genes coding for proteins that are involved in genome 
surveillance, such as DNA repair genes, are referred to as “caretakers”. 
Mutations or defects in such genes predispose an individual to cancer and 
may enhance tumorigenesis, a common condition in numerous hereditary 
cancer syndromes. Affected individuals inherit a defective allele of a caretaker 
gene and eventually acquire a mutation of the second allele in a somatic cell, 
an event that facilitates tumour survival and disease progression. Examples of 
inherited mutations in caretaker genes are those of the WRN DNA-helicase 
that are linked to the development of lymphomas, mutations in the BLM DNA-
helicase that result in a leukemia-prone phenotype and mutations in the 
BRCA1 or BRCA2 genes that lead to increased incidences of breast and 
ovarian cancers, respectively (Machwe et al. 2011). 
Current cancer chemotherapy is based on the use of chemical agents that 
cause a variety of DNA lesions: alkylating agents, such as methyl 
methanesulfonate (MMS), attach alkyl groups to DNA bases, while 
crosslinking agents such as mitomycin C (MMC), cisplatin and nitrogen 
mustard introduce covalent links between bases of the same DNA strand 
(intrastrand crosslinks) or of opposite DNA strands (interstrand crosslinks or 
ICLs). Other chemical agents, such as the topoisomerase I inhibitor 
camptothecin (CPT) and the topoisomerase II inhibitor etoposide, induce the 
formation of single-strand breaks (SSBs) or double-strand breaks (DSBs) by 
trapping topoisomerase-DNA covalent complexes (Helleday et al. 2008). 
Cancer cells are usually more susceptible to genotoxic agents than normal 
cells, likely due to the fact that they divide more rapidly than normal cells and, 
in addition, because cancer cells usually carry alterations in some 
components of DNA repair pathways that arise during tumour development. 
Another important consideration in this respect is that the high proliferation 
rate of cancer cells and the associated metabolic stress, like hypoxia and 
mitotic stress, renders them more reliant on anti-stress mechanisms, such as 
DDR pathways (Finn et al. 2011). Thus, combinatorial treatments with 
conventional DNA-damaging chemotherapeutic drugs and inhibitors of 
specific DNA repair pathways might prove to be the best choice in the 
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treatment of cancer. Proofs of this principle, called synthetic lethality, have 
been provided for the treatment of BRCA1-mutated breast cancers with 
PARP-inhibitors (Javle and Curtin, 2011). 
A deeper understanding of the mechanisms that are involved in the 
recognition and repair of DNA lesions may therefore provide the ground for 
designing novel strategies and therapeutic protocols in cancer treatment. The 
fact mentioned above, that components of DDR pathways are commonly 
mutated in cancer cells but are perfectly proficient in normal cells, offers a 
therapeutic window for this type of intervention and an edge over conventional 
cancer therapies. 
 
1.2. The DNA damage response 
To properly protect the genome, all types of DNA structural damages must be 
detected and repaired. This includes nicks, gaps, single strand breaks 
(SSBs), double strand breaks (DSBs) and all alterations that block DNA 
replication. To achieve this, mammalian cells have evolved a complex 
signaling network that senses DNA damage and replication stress and 
activates signal transduction cascades These, in turn, slow down transition 
through the cell cycle and activate DNA repair. Collectively, this signaling 
network is known as DNA damage response (DDR). 
Proteins that play a role in the DDR have been initially classified into four 
subtypes (Figure 1). Sensors are protein complexes or enzymes that 
recognize the DNA damage, bind to the altered DNA structures and initiate a 
signaling cascade by recruiting a second set of proteins referred to as 
transducers. Transducers are proteins of the phosphatidylinositol 3-kinase-like 
protein kinases (PIKK) family that includes ATM, ATR and DNA-PKcs or 
proteins of the poly(ADP-ribose) polymerase (PARP) family. PIKKs 
phosphorylate and activate the transducer kinases CHK1 and CHK2 that 
further amplify the signal and activate effector proteins via phosphorylation. In 
addition, effector proteins have been shown to undergo regulation by other 
post-translational modifications such as ubiquitylation. Effector proteins 
translate the signal into various cellular responses such as cell cycle arrest, 
senescence, DNA repair, transcriptional regulation or apoptosis. Recently, a 
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fourth subtype of proteins has been identified as an independent entity in the 
DDR pathway, the so-called mediators or adaptors. These are ATM and ATR 
substrates and essentially act as recruiters of additional substrates and as 
scaffolds to bring transducers in close proximity to their substrates and 
facilitate protein complex formation. 
 
 
 
 
Fig.1  
DNA damage response. The interactive signaling network of the DNA damage response, represented 
here as a linear pathway. DNA damage is recognized by sensor proteins that initiate a network of signal 
transduction cascades. This eventually results in the activation of effector proteins that mediate cell 
cycle arrest, the recruitment of DNA repair proteins, transcription or the induction of apoptosis. Modified 
after (Zhou and Elledg, 2000) 
 
1.2. DNA double-strand breaks 
DNA double-strand breaks (DSBs) are one of the most cytotoxic forms of 
DNA damage, and their faithful repair is critical for cell survival and the 
maintenance of genome integrity. DSBs can result from either endogenous or 
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exogenous sources. Naturally occurring DSBs can occur accidentally during 
DNA synthesis when replication forks encounter lesions that block their 
progression and eventually lead to fork collapse. Other important sources of 
endogenous DSBs are certain specialized cellular processes, including V(D)J 
recombination in developing lymphocytes, class-switch recombination at the 
immunoglobulin heavy chain (IgH) locus and meiosis (Longhese et al. 2009). 
DSBs are also produced when cells are exposed to DNA damaging agents 
including ionizing radiation (IR), which creates DSBs directly and indirectly via 
the generation of reactive oxygen species (ROS) (Ward J. 1998); chemical 
agents and UV light that create replication blocking lesions such as pyrimidine 
dimers and crosslinks (Bosco et al. 2004); and chemotherapeutic drugs that 
are used to treat cancer, such as camptothecin that poisons topoisomerase I 
producing replication-blocking lesions, or etoposide that inhibits 
topoisomerase II trapping the enzyme-DNA complex after DSB induction 
(Degrassi et al. 2004). Failure to repair DSBs, or their misrepair, can result in 
cell death or gross chromosomal rearrangements (GCRs) including deletions, 
translocations and chromosome fusions that enhance genome instability, 
promote carcinogenesis, accelerate aging and are hallmarks of cancer cells. It 
is well established that inherited defects in DSB repair genes cause 
embryonic lethality, sterility, developmental disorders, immune deficiencies 
and predisposition to neurodegenerative diseases and cancer. 
 
1.3.1 Double-strand break signaling  
The response to DSBs is coordinated in time and space and involves the 
assembly of a number of proteins at the DSB-flanking chromatin in a highly 
ordered and strictly hierarchical fashion. In mammalian cells, DSBs are 
directly sensed by the MRN (MRE11, RAD50, NBS1) complex. MRN is a 
highly conserved protein complex that plays a critical role in DNA damage 
sensing, signaling and repair. Its importance is illustrated by the fact that the 
genes (MRE11, RAD50 and NBS1) encoding the proteins for the MRN 
complex are vital for cell survival, since null mutations in any of the 3 genes 
lead to embryonic lethality in mice (Luo et al. 1999). Mutations in these genes 
cause human genome instability syndromes, namely ataxia-telangiectasia-like 
disorder (ATLD) if the MRE11 is mutated (Stewart et al. 1999), Nijmegen 
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breakage syndrome (NBS) if the mutation occurs in NBS1, and a variant form 
of Nijmegen breakage syndrome (NBS-variant) in RAD50 mutants (Waltes et 
al. 2009). The MRN complex has been shown to independently tether and 
process broken DNA ends. Moreover, it is required to recruit and activate the 
ATM (ataxia-telangiectasia mutated) kinase (Lee and Paul 2004). ATM 
belongs to the family of phosphatidylinositol 3-kinase-like protein kinases 
(PIKK), which also includes ATR (ataxia-telangiectasia and Rad3-related) 
kinase, DNA-PKcs (DNA protein kinase catalytic subunit), mTOR (mammalian 
target of rapamycin) and SMG1 (suppressor with morphological effect on 
genitalia). Of this family, only the first three members are involved in DDR.  
Activation of ATM in human cells is mediated by the autophosphorylation on 
S1981, resulting in the dissociation of latent ATM homodimer into active 
monomers (Bakkenist and Kastan, 2003). The exact mechanism by which 
ATM gets activated has been the subject of a long-standing debate and is 
likely to involve components that are yet to be discovered or that we do not 
currently appreciate in full (reviewed in Bekker-Jensen and Mailand, 2010). In 
addition to ATM, DNA-PKcs is also activated in response to DSBs under 
certain conditions and it facilitates their repair via non-homologous end joining 
(NHEJ). DNA-PKcs is believed to act redundantly with ATM as it can 
phosphorylate H2AX in ATM-deficient cells (Stiff et al. 2004). ATR signaling 
is more prominent in the presence of single stranded DNA stretches that are 
generated in response to UV photoproducts or bulky base adducts that cause 
replication fork stalling. Moreover, in response to DSBs, ATR activity is 
triggered in an ATM-dependent manner in the S and G2 phase of the cell 
cycle (Jazayeri et al. 2006). Jazayeri et al., as well as Shiotani and Zou 
demonstrated that this ATM-mediated ATR activation depends on the 
resection of DSBs. In this process, a DSB is sensed and bound by the MRN 
complex, which subsequently recruits ATM. Ongoing resection leads to the 
generation of single stranded DNA stretches that get coated by replication 
protein A (RPA). RPA provides a platform for the recruitment of ATR through 
its cofactor ATRIP (ATR-interacting protein) to the sites of DNA damage, 
resulting in ATR activation followed by ATM inactivation (Shiotani and Zou, 
2009).  
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Among the different targets of PIKKs is H2AX, a histone H2A variant that 
comprises 10-15% of total cellular H2A in higher eukaryotes (Rogakou et al. 
1998). While several of the PIKKs, including ATM, ATR and DNA-PKcs, are 
capable of phosphorylating H2AX, ATM has emerged as the main kinase 
responsible of performing this function (Stiff et al. 2004). Activated ATM 
phosphorylates H2AX at the conserved C-terminal S139 residue in response 
to DSBs (Burma et al. 2001). H2AX phosphorylation occurs on megabase 
regions flanking the DSBs within seconds of DNA damage, suggesting that 
H2AX phosphorylation may be a critical component in early DNA damage 
signaling (Rogakou et al. 1998). One key function of phosphorylated H2AX (γ-
H2AX) is to provide a high-affinity binding site for MDC1 (mediator of DNA 
damage checkpoint 1), which binds γ-H2AX via its C-terminal tandem BRCT 
repeats. MDC1 functions as a molecular bridge between γ-H2AX and the 
NBS1 component of the MRN complex, and helps providing a platform for 
various dynamic interactions for these and additional checkpoint and DNA 
repair proteins within the vicinity of the damage sites. Moreover, this 
interaction protects γ-H2AX from de-phosphorylation (Stucki et al. 2005). 
The key function of activating ATM/ATR signaling is the initiation of cell cycle 
arrest at G1/S, intra-S-phase and G2/M checkpoints. ATM phosphorylates the 
checkpoint kinase-2 (CHK2) at Thr-68, while ATR phosphorylates the 
checkpoint kinase-1 (CHK1) at Ser-317 and Ser-345 (Bartek and Lukas, 
2003). Specifically, ATM/ATR-dependent phosphorylation of CHK2 and CHK1 
facilitates intra-molecular auto-phosphorylation leading to full checkpoint 
kinase activation and further transmission of the signal to key cell-cycle 
regulators, including the CDC25 family of phosphatases, the kinase WEE1 
and p53, which itself can undergo phosphorylation by ATM at Ser-15. 
Temporal cell-cycle arrest induced in response to DNA damage is established 
through activation of the kinase WEE1 and inhibition of CDC25 activity, which 
results in inactivation of cyclin-dependent kinases (CDKs) at different stages 
of the cell cycle. A more sustained arrest is instead provided by p53-induced 
transcription of the CDK inhibitor p21 (Lukas et al. 2004). Cell cycle arrest 
presumably provides time to allow DNA repair to occur before the lesions are 
encountered by a replicative polymerase during DNA replication as well as to 
prevent the mis-segregation of chromosomal fragments during anaphase. 
Introduction 
 
 15 
1.3.2. Ionizing radiation-induced foci formation 
In response to DSBs, a number of proteins are recruited to the chromatin 
regions flanking the DNA lesion where they form aggregates. These protein 
aggregates are a hallmark of DSB signaling/repair and are so-called Ionizing 
Radiation-Induced Foci (IRIF; Bekker-Jensen and Mailand. 2010). Foci can be 
visualized by immunofluorescence and light microscopy as distinct speckles, 
in which one individual focus reflects protein accumulation at a single DSB. It 
has been demonstrated that DSB factors accumulate in the chromatin 
compartment flanking the DNA lesion in a hierarchical manner (Lukas et al. 
2004).  
The formation of γ-H2AX and the subsequent recruitment of MDC1 are 
exceedingly rapid, reaching maximal accumulation within minutes. This is 
then followed by a second wave of protein accumulation at DSBs (Mailand et 
al. 2007). This second wave of proteins arriving with delayed kinetics includes 
the DNA repair factors BRCA1 (breast cancer type 1 susceptibility protein) 
and 53BP1 (p53-binding protein 1), both being recruited via the instrumental 
role of an important ubiquitin ligase, the RNF8. Through its phospho-binding 
FHA domain, RNF8 directly binds MDC1 and gets recruited to the DNA 
damage sites. RNF8 then initiates a complex ubiquitylation cascade of 
histones H2A and H2AX at the DSB-flanking chromatin, an event that causes 
chromatin remodeling (Mailand et al. 2007). This initial ubiquitylation step 
leads to the recruitment of another E3 ubiquitin ligase, RNF168 that, through 
its two Motifs Interacting with Ubiquitin (MIUs), recognizes ubiquitylated forms 
of H2A and H2AX produced by RNF8. Subsequently, RNF168 extends 
ubiquitylation of H2A-type histones (Doil et al. 2009). These ubiquitin chains 
generated by the action of both RNF8 and RNF168 at the sites of DNA 
damage serve as “beacons” that mark the spot for the important downstream 
factors 53BP1 and BRCA1 (Figure 2). The ubiquitin-dependent recruitment of 
BRCA1 has been shown to be mediated through the so-called BRCA1 A 
complex (Huen and Chen, 2010). An important component of this complex is 
the RAP80 protein, which directly binds to ubiquitylated histones via its two 
Ubiquitin Interaction Motifs (UIMs) (Yan et al. 2007). The function of the other 
components of the BRCA1 A complex (Abraxas, BRCC36, BRE and NBA1), 
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are not yet completely clarified (Huen and Chen, 2010). The core component, 
Abraxas, remains stably expressed throughout the cell cycle in contrast to 
BRCA1 that exhibit low protein levels during G1. Thus, it is likely that Abraxas 
might have additional functions besides recruiting BRCA1 to damaged 
chromatin (Wang et al. 2009; Choudhury et al. 2004). The retention of 53BP1 
at sites of DNA damage is also dependent on the above mentioned 
ubiquitylation cascade, although neither bridging factors comparable to the 
BRCA1 A complex were identified for 53BP1 nor direct interaction between 
53BP1 and ubiquitylated H2A-type histones was observed. On the other 
hand, 53BP1 seems to be recruited to DSBs in a slightly different manner that 
employs its tandem Tudor domain. This domain has been shown to be 
capable of binding methylated Lysine residues on core histones, preferentially 
binding di-methylated H4K20 (Huyen et al. 2004; Botuyan et al. 2006). 
Nevertheless, the precise role of the Tudor domain in targeting 53BP1 to DNA 
damage sites remains elusive. A recent study by Pei et al. demonstrated that 
the histone methyltransferase MMSET is recruited to DSBs via its interaction 
with the BRCT domain of MDC1. MMSET then mediates the local methylation 
of H4K20 at the DNA damage sites that, in turn, facilitates 53BP1 recruitment 
(Pei et al. 2011).  
Due to the complex nature of the ubiquitylation cascades regulating IRIF 
formation, protein de-ubiquitylation via de-ubiquitylating enzymes (DUBs) 
likely plays an important role in the control of the duration and the magnitude 
of the response (Vissers et al. 2008). With the emerging roles of DUBs and 
the sumoylation machinery in regulating IRIF formation, this process could 
soon be exposed in its full complexity. 
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Fig. 2  
Model of IRIF formation and checkpoint activation. (1) MRN recognizes and binds to a DSB, thus 
facilitating recruitment of ATM. ATM undergoes autophosphorylation, which leads to dissociation into 
active monomers. ATM phosphorylates H2AX in the DSB-flanking chromatin. (2) The γH2AX is 
recognized by MDC1, which in turn further recruits MRN via interacting with NBS1. (3) MDC1 is 
phosphorylated and itself recruits the E3 ubiquitin ligase RNF8 as well as additional DDR proteins. This 
triggers a signaling cascade that is dependent on the ubiquitylation of H2A-type histones and ultimately 
results in checkpoint activation and DNA repair. Modified after (Jungmichel and Stucki, 2010)  
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1.3. The DNA damage checkpoints 
The term ‘cell-cycle checkpoint’ refers to mechanisms put in place to enforce 
dependency in the cell cycle by ensuring timely execution of process such as 
DNA replication or mitosis (Hartwell and Weinert, 1989). Thus, checkpoint 
pathways have the ability to control phase transitions. Given the critical 
significance of error-free DNA replication and chromosome segregation for 
the maintenance of genomic integrity and the prevention of cancer, cells have 
evolved the ability to trigger different cell cycle checkpoints upon DNA 
damage. These can transiently delay cell-cycle progression in G1, S or G2 
phases or even impose prolonged cell-cycle arrests in either G1 or G2 before 
entry into the subsequent S phase or mitosis (Figure 3). At the molecular 
level, common denominator of all checkpoint pathways is the inhibition of cell 
cycle "controllers", namely the cyclin-dependent kinases. These are protein 
complexes responsible of ensuring the timely triggering and the execution of 
key events at phase transitions. 
 
1.4.1. The G1/S checkpoint 
To prevent the replication of damaged DNA, cells exposed to genotoxic stress 
in G1 phase activate ATM/ATR. The latter, in a cascade of phosphorylation 
events, activate the downstream kinases CHK2/CHK1 that, in turn, directly 
phosphorylate the protein kinase WEE1. WEE1 phosphorylates CDK2 at two 
residues (Thr14/Tyr15) located in Gly-rich P-loop of the kinase, which is the 
ATP binding site. Such phosphorylation does not affect nucleotide binding but 
hampers catalysis (reviewed in Ferrari 2006). In addition, checkpoint kinases 
phosphorylate members of the CDC25 family of double-specificity 
phosphatases on several serine or threonine residues. CDC25 phosphatases 
specifically remove phosphate from the two inhibitory sites in CDKs ATP-
binding site, thus causing full activation of the CDK/Cyclin complexes 
(reviewed in Ferrari 2006). Whereas Cdc25B and -C are not required for 
mouse development or checkpoint function (Ferguson et al. 2005), and 
inhibition of these phosphatases by DNA damage essentially occurs by 
sequestration mechanisms (see below), CDC25A degradation via ubiquitin-
proteasome pathways is a primary control mechanism both in dividing cells 
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and in response to DNA damage (Donzelli et al. 2003). Phosphorylation of 
CDC25A at Ser-124 by CHK2 was reported to be the primary event 
responsible for ubiquitylation-dependent degradation of the phosphatase 
(Falck et al. 2001). Later work showed, however, the inconsistency of these 
observations (Jin et al. 2008). Specifically, phosphorylation of CDC25A on 
Ser-76 by CHK1 was shown to serve as priming event that facilitates 
phosphorylation on Ser-79 and Ser-82 by protein kinase CK1 or glycogen 
synthase kinase-3β (GSK-3β) (Kang et al. 2008; Honaker and Piwnica-
Worms, 2010). This, in turn, allows recruitment of the SCFβ-TRCP E3 ligase that 
promotes CDC25A ubiquitylation (Busino et al. 2003).  
The CHK1/CHK2-CDC25A checkpoint is rapid, since it is dependent on post-
translational modifications, but it is also transient and can delay the G1/S 
transition only for a few hours. If cells need to impose a prolonged G1 arrest, 
a second pathway involving the tumour suppressor p53 is activated. Briefly, 
upon DNA damage p53 is directly phosphorylated by both ATM/ATR at Ser-
15 and Ser-37 and the transducer kinases CHK2/CHK1 at Ser-20. In addition, 
the E3 ubiquitin ligase MDM2 that normally binds p53 and ensures rapid p53 
turnover, is targeted by ATM/ATR, as well as by CHK2/CHK1 (Maya et al. 
2001). These simultaneous modifications of p53 and MDM2 lead to disruption 
of the dimeric complex, p19ARF-mediated sequestration of MDM2 in the 
nucleolus with consecutive stabilization and accumulation of the p53 protein 
(Meek 2009). Acetylation of p53 at the C-terminal Lysines that were target of 
MDM2 as well as at additional sites in the DNA binding domain facilitate p53 
tetramerization, binding to its responsive elements in gene promoters and 
induction of transcription (Meek 2009). p53 most prominent target at the G1/S 
transition is p21CIP1/WAF1 (inhibitor of cyclin-dependent kinases). Specifically, 
p21CIP1/WAF1 inhibits kinase activity by physical engaging the complex with an 
inhibitory domain that stretches over both CDK2 and Cyclin E to obstruct 
substrate binding (Pei et al. 2005). Inhibition of CDK2/Cyclin E activity, in turn, 
results in incomplete phosphorylation of the tumor suppressor pRb, with 
consequent failure in releasing E2F1-3, the activating members of the E2F 
family of transcription factors, that are responsible for the transcription of 
Cyclin A and other S-phase genes (Attwooll et al. 2004) 
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1.4.2. The S-phase checkpoint 
During the S phase of cell cycle, human cells replicate the entire genome, 
which is composed of some three billion base pairs, to obtain two identical 
copies. In order to preserve genetic information, duplication must be carried 
out with highly fidelity. Cells encountering altered DNA structures during 
replication activate the so-called intra-S-phase checkpoint, which slows down 
ongoing DNA synthesis and prevents firing of new origins (Bartek et al., 
2004). This checkpoint operates via two parallel pathways, both of which are 
regulated by the ATM/ATR signaling cascade.  
One branch of these effector mechanisms is through the CDC25A-
degradation cascade described above. In addition to regulating 
CDK2/CyclinE, CDC25A is able to remove inhibitory phosphates from 
CDK2/CyclinA complexes to promote loading of the initiation factor CDC45 
onto chromatin. CDC45 is a protein required for the recruitment of DNA 
polymerase α into assembled pre-replication complexes, hence the inhibition 
of CDK2 activity results in the inhibition of new origin firing (Bartek and Lukas, 
2003). 
The other branch of the intra-S-phase checkpoint operates through the ATM-
mediated phosphorylation of NBS1 (Shiloh. 2003) and SMC1 (Structural 
maintenance of chromosomes 1) (So et al. 2011) on several sites. However, 
how phosphorylated SMC1 contributes in slowing down DNA replication is 
unknown. 
Both branches of the intra-S-phase checkpoint lead to a transient slow down 
of DNA replication, allowing the repair of lesions before completion of 
replication. In case of failure to repair damage during this transient delay, cells 
complete replication and exit S phase. However, cells subsequently arrest in 
the G2 phase to tackle the persistent DNA damage. 
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Fig.3 
Cell-cycle checkpoints pathways. In response to DNA damage the checkpoint kinases ATM and ATR 
phosphorylate several targets including the transducing kinases CHK2 and CHK1. Phosphorylation of 
CHK2 and CHK1 leads to their activation and further transduction of the checkpoint signal to other 
important cell-cycle regulators, including the kinases WEE1/MYT1 (not shown), the CDC25 
phosphatases and p53. Inhibition of CDKs leads to transient cell-cycle arrest, whereas p53 regulates 
the transcription of genes involved in DNA repair and apoptosis. Modified after: (Kastan and Bartek, 
2004). 
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1.4.3. The G2 checkpoint 
The G2 checkpoint prevents cells from entering mitosis when they suffer DNA 
damage during transition through the G2 phase, or alternatively if they have 
progressed into G2 with unrepaired DNA lesions that occurred during the 
previous S or G1 phases. As sketched for the G1/S checkpoint, the final 
target of the G2 checkpoint is a CDK. Signals from unfinished DNA replication 
(through ATR/CHK1) or damaged DNA (through ATM/CHK2) activate the 
kinases WEE1/MYT1 that, in turn, phosphorylate active CDK1/CyclinB 
complexes causing inhibition of enzymatic activity. In parallel, checkpoint 
kinases phosphorylate CDC25 phosphatases (Donzelli and Draetta, 2003). 
Particularly, CHK1-dependent phosphorylation of CDC25A at Ser-124 and 
Thr-507 and of CDC25C at Ser-216 mediate recruitment of 14-3-3 proteins 
that displace the phosphatases from the nucleus, a mechanism that appears 
to be the primary way employed to inhibit CDC25A as well as CDC25C 
function during G2 and mitosis (Uto et al. 2004). The mechanism of inhibition 
of CDC25B, which mediates the activation of CDK1/Cyclin B at the 
centrosome during prophase, has been extensively studied in relation to its 
mitotic role (Gabrielli 1996) but is less characterized in response to DNA 
damage. 
Moreover, additional factors upstream of CDC25 or cyclin B/CDK1, such as 
the Polo-like kinases PLK3 and PLK1 (Nyberg et al. 2002), the PLK1 activator 
AurA (Krystyniak et al. 2006) and protein phosphatase PP2A (Yan et al. 2010) 
are also part of the G2/M checkpoint. Similar to G1 checkpoint, maintenance 
of the G2/M checkpoint partly relies on transcriptional regulation by p53 that, 
upon stabilization, induces transcription of the cell-cycle inhibitor p21CIP1/WAF1. 
In addition, the expressions of 14-3-3σ (a scaffold and signaling protein), 
PUMA (BCL2 binding component 3), BAX (BCL2 partner and apoptotic 
activator), GADD45 (growth arrest and DNA-damage-inducible gene) are also 
regulated and are required for efficient arrest (Nyberg et al. 2002; Taylor and 
Stark, 2001).  
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1.4. DNA double-strand break repair 
Classically, two conceptually different mechanisms can in principle repair 
DSBs occurring in the genome of higher eukaryotes: Non-homologous end 
joining (NHEJ) and homologous recombination repair (HR) (Heyer et al. 
2010). As their names imply, NHEJ simply restores integrity in the DNA by 
joining the two ends without necessarily preserving the original sequence. As 
a result, it is error-prone. Because a second DNA molecule is not required for 
the function of this repair pathway, it is active throughout the cell cycle. HR, 
on the other hand is equipped to maintain fidelity in the sequence of the DNA 
molecule. To achieve this, HR requires an undamaged homologous sequence 
that serves as template for repair of the broken strands. There are two 
sources of homology in mammalian cells. The homologous chromosome that 
is present throughout the life cycle of the cell and the sister chromatid that is 
generated after DNA replication and which, therefore, exists only during the S 
and G2 phases of the cell cycle. Accumulating evidence supports the view 
that HR uses the sister chromatid as template rather than homologous 
chromosomes, a requirement that restricts the function of this pathway to the 
S and G2 phases of the cell cycle (Heyer et al. 2010). This requirement 
probably derives from the fact that in a eukaryotic cell nucleus the 
homologous chromosomes are accommodated in distinct and frequently 
distantly located domains that renders difficult the search for homology (a key 
step of HR) (Folle. 2008).  
The fact that at least two genetically and conceptually distinct repair pathways 
are involved in the repair of DSBs raises questions regarding their 
coordination. If these pathways operate independently of each other it is 
possible that they compete against each other. On the other hand, if they 
collaborate, then the question is how their functions are coordinated. As 
stated above, the choice between the two pathways depends on the phase of 
the cell cycle. Studies of either NHEJ- or HR-deficient cells suggest that these 
two pathways compete for the repair of DSBs (Delacote et al. 2002). HR-
deficient cells have a significant DSB repair defect only during the S/G2/M 
phases, whereas NHEJ-deficient cells showed reduced repair efficiency at all 
cell cycle stages (Hinz et al. 2005; Rothkamm et al. 2003). The mechanisms 
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by which cells decide between these two repair pathways have been studied 
for the past few years. According to the evidence obtained so far, DNA-end 
resection is a critical step that favors the choice of HR over NHEJ and it is 
regulated by cyclin-dependent kinases (CDKs) (Jazayeri et al. 2006), the 
master regulators of the cell cycle. Analysis carried out in yeast revealed that 
inhibition of CDK1/cdc28 in the G2-phase prevented end resection and 
checkpoint activation as well persistence of Mre11 at DSB sites, consistent 
with the idea that processing of the break had stalled (Ira et al. 2004). The 
authors also showed that CDK1 controls Mre11-associated nuclease function 
at the DSB, but does not influence its recruitment to DNA ends. In addition, 
Sae2, a DNA endonuclease that controls the initiation of DNA end resection in 
yeast (Lengsfeld et al. 2007; Clerici et al. 2005) is regulated by CDK-
dependent phosphorylation (Huertas et al. 2008). Mutation of Sae2 Ser-267 to 
the non-phosphorylatable residue alanine (S267A) caused an end-processing 
phenotype comparable with deletion of Sae2. In contrast, mutating the same 
residue into a residue that mimics constitutive phosphorylation (S267E) 
complemented these phenotypes and bypassed the need for CDK activity in 
DSB end resection (Huertas et al. 2008). The Sae2-null and S267A mutants 
showed delayed HR and enhanced NHEJ, whereas the S267E mutant 
showed slightly enhanced recombination and a decrease in NHEJ. This 
indicates that CDK1/cdc28-mediated phosphorylation of Sae2 in yeast 
regulates the balance between HR and NHEJ during the cell cycle. The motif 
of Sae2 that contains the residue Ser-267 is highly conserved amongst 
orthologs in higher eukaryotes, and mutation of the analogous residue in 
human CtIP also resulted in hypersensitivity to camptothecin (Huertas et al. 
2008). These results suggest that similar CDK control of DNA end resection 
exists in other organisms.  Moreover, phosphorylation of a putative CDK site 
in human CtIP enables it to interact with the BRCA1 C-terminal tandem BRCT 
domain, an interaction that is required for efficient end resection (Yu and 
Hiom, 2009). This, in turn, suggests that the BRCA1-CtIP interaction 
influences the balance between HR and NHEJ. Collectively, these results 
support a model in which the commitment to DSB end resection and repair is 
regulated in order to ensure that the cell activates the most appropriate DSB 
repair pathway to optimize genome stability. 
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1.5.1. Non-homologous end-joining 
NHEJ is the major pathway for DSBs repair in mammalian cells. It involves 
joining the two ends of a DSB through a process largely independent of 
homology. NHEJ provides a relatively simple mechanism for the repair of 
DSBs throughout the cell cycle, but of particular importance during G0-, G1-, 
and early S-phase (Delacote and Lopez, 2008). NHEJ only works efficiently 
and with high fidelity in the repair of DSBs displaying complimentary 
overhangs, 5’ phosphates and 3’ hydroxyl groups, so called ‘clean’ DSBs, 
such as those produced by nucleases. In yeast and mammalian cells, 
approximately 25-50% of nuclease DSBs is repaired by precise NHEJ 
(Clikeman et al. 2001). If the ends are not compatible, then processing is 
required and this can result in mutagenic deletions or insertions at the break 
site (Symington and Gautier, 2011). The molecular mechanism by which 
NHEJ operates could be simplified in three main steps: first both ends of the 
broken DNA are captured, second a molecular bridge is formed to bring the 
two DNA ends back together and, finally, the broken DNA ends are re-ligated.  
 
Central to NHEJ in organisms from yeast to man is the Ku protein, a 
heterodimer of two subunits called Ku70 and Ku80 (Lieber 1999). Biochemical 
studies of mammalian Ku have showed that it can bind DNA in a non-
sequence-dependent manner and that binding is dependent on DNA DSBs 
(Walker et al. 2001). The NHEJ process (Figure 4) is initiated by the binding 
of the Ku70/80 heterodimer to both ends of the broken DNA molecule, forming 
a ring-shaped structure, in which the opening of the ring accommodates a 
DNA helix. This feature allows the Ku heterodimer to slide over the ends of a 
broken DNA molecule (Walker et al. 2001). It is believed that the association 
of a DNA end with the Ku heterodimer creates a platform for the assembly of 
other NHEJ key enzymes and proteins. In vertebrates, Ku serves as the DNA 
targeting subunit for the DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs), which together with the Ku forms the DNA-PK holoenzyme. The 
association of the DNA-PKcs with DNA activates its serine/threonine kinase 
activity. Among the different phosphorylation targets of DNA-PKcs are 
XRCC4, the nuclease Artemis and DNA-PKcs itself, which can undergo 
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autophosphorylation. This autophosphorylation is believed to influence its 
conformation and dynamics, serving to relieve blockage of the ends by DNA-
PKcs, hence facilitating access of other repair factors (Weterings et al. 2003). 
Occasionally, the generated DSBs might require further processing to 
generate ligatable 5’-phosphorylated ends in order for repair to be completed. 
The nuclease Artemis, a single-stranded 5’-3’ exonuclease, which upon 
phosphorylation by DNA-PKcs acquires an additional endonuclease activity 
specific for hairpins and ssDNA overhangs, as well as the polynucleotide 
kinase (PNK), together with DNA-PKcs have been shown to stimulate DNA-
processing for efficient NHEJ (Ma et al. 2002). The processed DNA-ends 
might lead to the generation of DNA gaps that are filled in by DNA 
polymerases. Members of the DNA polymerase X family of polymerases, 
including polymerase µ, polymerase λ and terminal 
deoxyribonucleotidyltransferase (TdT), have been shown to fill the gaps 
generated during NHEJ (reviewed in McElhinny and Ramsden. 2004). Finally, 
NHEJ is completed by ligation of the DNA ends, a step carried out by the 
NHEJ ligase complex (also known as X4-L4), which is composed by XRCC4, 
DNA ligase IV and XLF (Grawunder et al.1997). 
Alternative NHEJ acts in the absence of classical NHEJ factors such as Ku, 
XRCC4 or DNA ligase IV. There, repair events involve small deletions and 
require short stretches of homology between the ligatable DNA ends. 
Microhomology-mediated end-joining (MMEJ) is the dominant pathway during 
alternative end-joining. In this repair mechanism DNA is slightly resected (less 
than 100 nucleotides) to expose regions of homology, which lead to 
reattachment of the two DNA ends of the break. The DNA is further processed 
by nucleases that remove flaps and overhangs and eventually by DNA 
polymerases that fill in the gaps (Bennardo et al. 2008). 
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Fig. 4  
NHEJ in mammalian cells. The Ku70/80 heterodimer binds broken DNA ends and recruits DNA-PKcs, 
which in turn tethers the DNA termini together. DNA-PKcs undergoes autophosphorylation-induced 
conformational alterations that allow the recruitment of Artemis and DNA polymerases of the X family of 
polymerases to generate ligatable DNA ends. Finally, the Ligase IV/XRCC4/XLF complex completes 
repair by ligating the two DNA ends. Modified after (Hartlerode and Scully, 2009)  
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1.5.2. Homologous recombination  
The goal of HR is to facilitate recovery of information lost as result of damage 
to both strands by retrieving it from an undamaged homologous DNA 
sequence. To this end, damaged and undamaged DNA molecules need to 
directly interact. In particular, the damaged DNA molecule will need to first 
undergo processing in order to generate DNA structures that can “read-off” 
sequence information. Furthermore, the chromatin structure on both DNA 
molecules will need to be modified in order to facilitate the search for the 
homologous sequences in the sister DNA molecule. Once homology has been 
found, sequence information will need to be copied and finally the interacting 
DNA molecules will need to be separated. 
HR starts with the resection of DNA ends around the DSB, forming 3’-single 
stranded DNA (ssDNA) stretches (Wyman and Kanaar, 2006). This form of 
DNA can invade and pair to homologous sequences present in an intact DNA 
molecule and is also suitable to be extended by DNA polymerases to copy the 
missing sequence information. In higher eukaryotes, initial resection of DNA 
ends is orchestrated by the MRN complex (D’Amours and Jackson, 2002), 
assisted by the function of the resection-promoting factor CtIP [CTBP (C-
terminus-binding protein of adenovirus E1A)-interacting protein] (Sartori et al., 
2007; Farah et al. 2009). These proteins collaborate to trim the DNA ends to 
an intermediate form in a process so-called “short-range” resection. The 
trimmed DSB is then resected more extensively in a step of “long-range” 
resection (Sartori et al. 2007; Jazayeri et al. 2006). Possible candidates are 
the exonuclease-1 (EXO1) and the Bloom’s syndrome protein (BLM) together 
with the nuclease DNA2 (Gravel et al. 2008; Nimonkar et al. 2011). The 
single-stranded 3’-overhangs generated in this process are coated by the 
replication protein A (RPA) heterotrimer, the major mammalian ssDNA binding 
protein (Figure 5). This rapid binding by RPA is believed to protect the ssDNA 
and to prevent the formation of secondary DNA structures (Fanning et al. 
2006). In addition, RPA also mediates the recruitment of the ATR/ATRIP 
complex to the single stranded regions and initiates the DDR signaling 
cascades, which among others inhibit cell cycle progression through 
activation of the corresponding checkpoints (Cimprich and Cortez, 2008).  
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Fig. 5 
Model for DNA double-strand break resection. The MRX complex in yeast or MRN in mammals 
recognizes DSBs. Mre11/MRE11 collaborates with the endonuclease Sae2/CtIP to trim the DNA ends, 
leaving short 3’-single stranded DNA overhangs. The DNA ends are further resected by either the 
Exo1/EXO1 exonuclease or by the Sgs1/BLM helicase and the Dna2/DNA2 nuclease, generating long 
stretches of ssDNA that are coated by RPA. Modified after (Bernstein et al. 2010). 
 
The subsequent DNA strand invasion and homology search requires the 
formation of a nucleoprotein filament composed of Rad51 bound to ssDNA. 
Since RPA binds more avidly to ssDNA than Rad51, additional activities are 
required to load Rad51 onto RPA-coated ssDNA and to displace RPA. In 
mammalian cells, an important mediator complex is BRCA1/BARD1 and 
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BRCA2 (FANCD1)/DSS1, bridged by the PALB2 (partner and localizer of 
BRCA2) (FANCN) (Zhang et al. 2009). Loading of Rad51 is believed to occur 
through its direct interaction with BRCA2 (Pellegrini et al. 2002). This 
interaction is thought to be limited to S and G2 phases of the cell cycle, since 
CDK-dependent phosphorylation of BRCA2 during progression to mitosis 
leads to disruption of the complex (Esashi et al. 2005). The Rad51 
nucleoprotein filament then invades a duplex DNA of the sister chromatid and 
searches for homology. Once found, the invading strand sets up a structure, 
which involves pairing with the complementary strand and displacement of the 
other, resulting in a so-called D-loop (displacement loop) structure. At this 
point, HR can be completed via several pathways and different outcomes. 
Synthesis-dependent strand annealing (SDSA) or double strand break repair 
(DSBR) have been described to occur in case of two-ended DSBs. In SDSA 
the elongated invading strand pairs with the second DSB end (Figure 6 
pathway C). This process only produce non-crossovers, hence SDSA is the 
preferred recombination-mediated pathway for DSB repair in somatic cells to 
prevent loss of heterozygosity. Alternatively, during DSBR, the D-loop gets 
extended and captures the second DSB end, creating a double Holliday 
junction (HJ) between the four strands that can undergo branch migration, a 
process catalyzed by members of the RecQ helicase family (West 2003). HJ 
intermediates can be resolved in different ways resulting in either non-
crossovers or crossovers, the later being predominant during meiotic 
recombination (Figure 6 pathway D and E). The BLM/Topo IIIα can dissolve 
HJ to form non-crossover products (Wu and Hickson, 2003). Alternatively, the 
MUS81-EME1 complex may cleave HJs to yeild crossovers (Chen et al. 
2001). Two more HJ resolvases that has been recently identified in humans 
cells, GEN1 and SLX1/SLX4 promotes the resoultion of HJs by a mechanism 
that is believed to generate crossovers and non-crossovers (Ip et al. 2008; 
Svendsen et al. 2009; Fekairi et al. 2009). 
In the abscence of a homology, single-strand annealing (SSA) can be the 
pathway of choice. SSA involves the exposing of repetitive sequences by 
resection of both 5’-strands until sequences are uncovered and annealed 
(Figure 6  pathway F). DNA flaps are then removed by nucleases followed by 
DNA synthesis and ligation of the nicks. Since SSA involves the deletion of 
Introduction 
 
 31 
the intervening sequences, it is considered as a mutagenic repair pathway. 
One-ended DSBs generated through uncapping telomeres or collapsed 
replication forks after encountring a single strand break (SSB) or nick, are 
repaired by break-induced repair (BIR) (Figure pathway 6 G). In BIR, the 
invading 3’-strand forms a replication fork that copy long tracts from the donor 
DNA molecule. This process could potentially lead to loss of heterozygosity. 
 
                   
Fig. 6   
Homology recombination in mammals. (A and B) The DSB is recognized by the MRN complex, which 
tethers the broken DNA ends and collaborates with the CtIP/BRCA1/BARD1 complex in DNA-end 
resection. The generated ssDNA is rapidly coated by the ssDNA binding protein RPA to prevent the 
formation of secondary structures. BRCA1/BARD1 promotes the accumulation of BRCA2 via PALB2. 
BRCA2 catalyze the loading of RAD51 to displace RPA molecules and form RAD51 nucleoprotein 
filaments. The RAD51 filament captures duplex DNA and searches for homology. Different repair 
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pathways can be initiated: (C) In SDSA the extended invading strand is displaced and anneals with the 
resected second DNA end. (D) In the DSB repair pathway both DNA ends are captured by annealing to 
the extended D-loop, forming a double HJ, which is resolved to generate either crossover or non-
crossover products. (F) During SSA, direct repetitive sequences are revealed by resection of 
complementary strands that can be annealed while intervening sequences are deleted. (G) In BIR the 
3’-end of the invading strand forms a replication fork that copy long tracts of the donor DNA strand. 
Modified after (Hartlerode and Scully. 2009). 
 
 
1.6. DNA nucleases 
 
1.6.1. General features of DNA nucleases 
DNA, the carrier of genetic information of the majority of living organism, is 
composed of a sugar-phosphate backbone and four organic bases. DNA 
suffers from various environmental stresses, including damage caused by UV 
light, radiation and carcinogens that constantly modify its structure. Moreover, 
DNA accumulates errors that are intrinsic to the process of replication and 
displays unusual structures during recombination. In order to avoid alterations 
of the base sequence or entanglement of the DNA, these modifications must 
be corrected by the various repair protein machineries present in the cell. 
Such DNA repair proteins usually form complexes with other proteins, likely to 
facilitate targeting and gain efficiency. A core component of these complexes 
are nucleases, which play crucial roles in recognizing and processing 
replication or recombination intermediates. In addition, through their 
participation to various DNA repair processes such as mismatch repair 
(MMR), base excision repair (BER), nucleotide excision repair (NER) and 
double strand break repair, they also play a role in resolving DNA mismatches 
that occur during replication or eliminating damaged nucleotides. 
Nucleases can be regarded as molecular scissors that catalyzes the cleavage 
of phosphodiester bonds between the phosphate and the sugar moieties in 
the backbone of the DNA. Nucleases can be generally divided into 
exonucleases and endonucleases. Exonucleases can be further classified as 
5’-end processing or 3’-end processing enzymes, according to the polarity of 
consecutive cleavage. On the other hand, endonucleases hydrolyze internal 
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phosphodiester bonds within a polynucleotide chain, without the requirement 
of a free DNA end. 
 
1.6.2. Exonuclease 1 (EXO1) 
EXO1 is a member of the Rad2 family of nucleases. It was originally identified 
in the fission yeast Schizosaccharomyces pombe upon induction to undergo 
meiosis (Szankasi and Smith, 1992). S. pombe Exo1 was shown to catalyze 
the removal of mononucleotides from the 5’ end of a DNA duplex or DNA 
nicks displaying 5’-3’ polarity, acting preferentially on double-stranded DNA 
ends (dsDNA) to produce 3’ single stranded overhangs (Szankasi and Smith, 
1992). The human EXO1 gene encodes a protein that bears only 27% identity 
to its yeast ortholog (Tishkoff et al. 1998). However, it has been demonstrated 
that human EXO1 can complement the DNA damage sensitivity and the 
mutator phenotype that result from deletion of Exo1 in Saccharomyces 
cerevisiae (Qiu et al. 1999), indicating that at least certain aspects of EXO1 
function appear to be conserved. In vitro, human EXO1 was show to be a 
structure specific nuclease, possessing 5’-3’ exonuclease and 5’-flap 
endonuclease activities (Lee et al. 1999). EXO1 molecular mechanism of 
action was recently clarified and shown to be similar to that of other FEN 
nucleases (Orans et al. 2011)  
EXO1 is involved in several DNA repair pathways including MMR, double 
strand break repair, post-replication repair as well as meiotic and mitotic 
recombination (Tran et al. 2004). The first established role for yeast EXO1 
was deduced from its ability to physically interact with yeast and human 
MSH2 (Tishkoff et al. 1997), followed by the demonstration of its participation 
in MMR (Tishkoff et al. 1997; Tishkoff et al.1998). It was later demonstrated 
that EXO1 plays both catalytic and structural roles during MMR-mediated 
repair (Tran et al. 2002; Amin et al. 2001). Briefly, upon detection of a 
mismatched base, the MMR machinery is recruited (Figure 7), EXO1 carries 
out a controlled excision step that removes nucleotides in the newly made 
strand past the mismatch, creating a ssDNA gap that serves as a platform for 
DNA polymerase. The polymerase fills in the excised stretch and, finally, a 
DNA ligase seals the nick completing MMR (Jiricny 2006).  
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The involvement of EXO1 in DNA repair pathways suggests that it could play 
an important role in tumourigenesis. Consistent with this, a cancer-prone 
phenotype has been observed in Exo1-defiecient mice, where a clearly 
increased susceptibility to lymphoma development was observed (Wei et al. 
2003). 
                         
 
 
Fig. 7 
The role of EXO1 in MMR. A single base-pair mismatch is detected and bound by MSH2-MSH6 
heterodimers. This leads to the recruitment of the MMR machinery, including EXO1. The mismatched 
base is removed by an excision step executed by EXO1 and the generated gap is filled by DNA 
polymerases and DNA ligase. Modified after (Martin and Scharff. 2002). 
  
Mounting evidence has shown that EXO1 plays an important role in DSB 
repair by executing a long-range resection step to generate extended 
stretches of ssDNA. This ssDNA serves to induce cell cycle checkpoints and 
is required for RAD51 mediated strand invasion of the sister chromatid for an 
efficient HR cascade. Cells depleted of EXO1 show chromosomal instability, 
hypersensitivity to IR and defects in HR-dependent DSB repair (Bolderson et 
al. 2010). Studies on the mechanism of DSB repair established that the MRN 
complex detects a DSB and, collaborating with CtIP, promotes DNA end 
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resection generating short ssDNA overhangs (Sartori et al. 2007). This initial 
resection step is followed by a more extensive step of resection carried out by 
redundant enzymes with EXO1 being an important exonuclease among them 
(Figure 8) (Mimitou and Symington, 2009). 
 
                   
 
Fig. 8 
DSB resection. The MRN complex (MRX in yeast) detects and binds a DSB. Together with CtIP (Sae2) 
they trim the free DNA ends creating short ssDNA overhangs that are suitable for a second resection 
step carried out by EXO1 (Exo1) or by the Sgs1 (BLM1) helicase and a single-stranded specific 
nuclease, believed to be DNA2 (Dna2). Modified after (Mimitou and Symington, 2009). 
 
Accumulating evidence suggests that EXO1 plays also an important role at 
the replication fork. Data from Saccharomyces cerevisiae demonstrated that 
Exo1 acts in a redundant manner with Rad27 (FEN1 in human) in processing 
Okazaki fragments during the process of DNA replication (Tran et al. 2002). 
Moreover, Exo1 was shown to be recruited to stalled replication forks where it 
plays a role in preventing fork reversal by resecting newly synthesized strands 
and helping to resolve sister chromatid junctions (Cotta-Ramusino et al. 
2005). 
EXO1 nucleolytic activity is tightly regulated under DNA replication stress and 
other cellular responses to DNA damage. It was demonstrated in our and 
other laboratories that such control is exerted either by post-translational 
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modifications or by direct interaction with other proteins. Previous results from 
our laboratory showed that upon replication fork stalling in mammalian cells, 
EXO1 is phosphorylated in an ATR-dependent manner, a step that targets it 
to ubiquitin-mediated degradation through the proteosome pathway (El 
Shemerly et al. 2005; El Shemerly et al. 2008). In the study that is object of 
this thesis, we show that the interaction with CtIP restrains the exonucleolytic 
activity of EXO1 in vitro (Eid et al. 2010). Others have shown that, in response 
to ionizing radiation, ATM-mediated phosphorylation of EXO1 causes a 
decrease of its enzymatic activity, thus allowing to load RAD51 and complete 
HR (Bolderson et al. 2010). In line with this evidence, results from yeast 
demonstrated that Mec1-dependent phosphorylation of Exo1 modulate its 
activity at uncapped telomeres (Morin et al. 2008). 
 
1.6.3. CtBP-interacting protein (CtIP) 
CtIP, a protein conserved from yeast to humans, plays a critical role in 
multiple molecular pathways. Human CtIP was first identified by a yeast two-
hybrid (Y2H) assay as one of the interacting proteins of the transcriptional 
suppressor CtBP (C terminus-binding protein) (Schaeper et al. 1998). CtBP 
binds to the c-terminal of adenovirus E1A, resulting in anti-tumourigenic 
activity (Boyd et al. 1993). Several other Y2H screenings with different “baits” 
identified CtIP. In another Y2H screen, in which the tumor suppressor 
retinoblastoma (Rb) protein was used as bait, CtIP was identified as RBBP8 
(Retinoblastoma-binding protein 8) (Fusco et al.1998). Moreover, CtIP/RBBP8 
was also found to associate with the Rb-related protein p130 in a different 
Y2H screen (Meloni et al. 1999). CtIP has also been isolated in another Y2H 
assay with LMO4 used as bait. LMO4 belongs to the LIM-only (LMO) group of 
transcriptional regulators (Sum et al. 2002). CtIP orthologs were also 
identified in yeast. Sae2/COM1 was identified in the budding yeast 
Saccharomyces cerevisiae (Prinz et al. 1997) and ctp1 was isolated from the 
fission yeast Schizosaccharomyces pombe (Limbo et al. 2007). 
CtIP and its orthologs are involved in several biological processes. Among 
these is transcriptional regulation, where CtIP plays a central role by 
interacting with several proteins, primary among them being CtBP. CtBP acts 
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as a transcriptional co-repressor of a number of tumor suppressors such as 
PTEN and E-cadherin (Chinnadurai 2009). However, contrary to the proposed 
role of co-repressor, chromatin-immunoprecipitation (ChIP) experiments 
showed that CtIP can bind its own promoter and the promoter of another 
important E2F target such as cyclin D1 in late G1 and at the G1/S transition. 
In these experiments it was shown that concomitantly with the release of pRb, 
CtIP facilitated the G1/S progression by activating transcription of a subset of 
E2F-responsive genes (Liu and Lee, 2006). In addition, it was also shown that 
CtIP can interact with the general transcription factors TATA binding protein 
(TBP) and transcription factor IIB (Koipally and Georgopoulos, 2002). 
The role of CtIP in DSB repair (Figure 9) has been extensively studied. As 
mentioned above, CtIP plays an important role in HR by virtue of its function 
in the initial end-trimming of broken DNA ends of a DSB, a step that requires 
the combined action of both the MRN complex and CtIP (Sartori et al. 2007). 
Phosphorylation of Sae2 (Ser-267) by Cdc28 and of CtIP (Thr-847) by CDK2 
is important for this initial resection step. Mutating this site into alanine was 
demonstrated to prevent phosphorylation and impair resection (Huertas and 
Jackson, 2009). Moreover, CtIP depletion using specific siRNA 
oligonucleotides sensitizes human cells to camptothecin and impairs HR 
(Sartori et al. 2007). CtIP is required not only for HR repair in S and G2 
phases of the cell cycle but also for a specialized end-joining pathway known 
as microhomology-mediated end joining (MMEJ) or alternative-NHEJ (A-
NHEJ), which is activated in G1 phase of the cell cycle upon generation of 
DSBs in human cells (Yun and Hiom, 2009; Quennet et al. 2010). 
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Fig. 9 
Roles of CtIP in DSB repair. DSBs are detected and bound by the MRN complex that, together with 
CtIP, promotes an initial short-range resection step, generating short 3’- ssDNA overhangs. This is 
followed by a second more extensive resection step that is executed by EXO1 and/or other nucleases 
and helicases to promote homologous recombination in the S/G2 phases of the cell cycle. In addition, a 
DSB bound by MRN is processed by the combined action with CtIP to free DNA termini, leading to a 
microhomology search and subsequent gap ligation through a pathway called alternative NHEJ. 
Alternatively, a DSB can be bound by Ku70/86 heterodimer that activate the classical NHEJ pathway. 
Modified after (Tsutsui et al. 2011) 
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ABSTRACT 
DNA end resection, essential for the repair of DNA double-strand breaks 
(DSBs) by homologous recombination, relies initially on the partnership 
between MRE11-RAD50-NBS1 (MRN) and CtIP, followed by a processive 
step involving helicases and exonucleases such as EXO1. Here, we show 
that EXO1 localization to DSBs depends on both CtIP and MRN. Furthermore, 
we establish that CtIP interacts with EXO1 and restrains its exonucleolytic 
activity in vitro. Finally, we reveal that upon exposure to camptothecin, 
depletion of EXO1 in CtIP-deficient cells increases the frequency of DNA-PK-
dependent radial chromosome formation. Thus, our study uncovers novel 
important functions of CtIP and EXO1 in DNA end resection and sheds new 
light on the regulation of DSB repair pathways, a key factor in the 
maintenance of genome integrity. 
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INTRODUCTION 
DNA double-strand breaks (DSBs) are the most cytotoxic lesions that can be 
generated by ionizing radiation (IR), certain chemotherapeutic drugs, collapse 
of stalled DNA replication forks or during physiological processes such as 
meiotic recombination (Bassing et al, 2002; Whitby, 2005). Misrepaired DSBs 
may cause gross chromosomal aberrations that, in turn, trigger 
carcinogenesis through activation of oncogenes or inactivation of tumor 
suppressor genes. Cells utilize two main mechanisms to repair DSBs: non-
homologous end-joining (NHEJ) and homologous recombination (HR) (Misteli 
& Soutoglou, 2009; Wyman & Kanaar, 2006). Rejoining of DSBs by NHEJ 
takes place throughout the cell cycle, whereas HR is restricted to S and G2 
phases. HR is initiated by 5’-3’ resection of DSBs to produce single-stranded 
DNA (ssDNA) tails that function as a signal for ATR-mediated DNA damage 
checkpoint activation prior to the recruitment of recombination proteins (Pardo 
et al, 2009).  
A wealth of studies has addressed the molecular mechanisms of DNA end 
resection in different genetically amenable organisms. The evidence obtained 
has implicated the MRE11-RAD50-NBS1/Xrs2 (MRN/MRX) complex together 
with CtIP/Sae2 in the early stages of DSB processing, followed by the 
redundant action of BLM/Sgs1 helicase and exonuclease 1 (EXO1) in the 
generation of long stretches of ssDNA (Mimitou & Symington, 2009). 
Accordingly, only the simultaneous depletion of BLM and EXO1 resulted in 
accumulation of partially resected intermediates and hypersensitivity to DSB-
inducing agents (Gravel et al, 2008; Mimitou & Symington, 2008; Zhu et al, 
2008). These studies led to a two-step model according to which in human 
cells the initial “end-trimming” is carried out by MRN and CtIP, followed by a 
processive step of resection involving two alternative mechanisms depending 
either on EXO1 or BLM (Niu et al, 2009). 
Here we show that EXO1 is recruited to laser-induced DSBs in a CtIP-
dependent manner and that CtIP interacts with EXO1, thereby retarding 
processive degradation of DNA by EXO1 in vitro. Furthermore, we provide 
evidence that concomitant depletion of CtIP and EXO1 in camptothecin-
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treated cells leads to chromosomal rearrangements, which is likely the result 
of illegitimate NHEJ-dependent repair of DSBs. 
 
RESULTS AND DISCUSSION 
 
EXO1 localization to sites of DNA damage  
Based on the proposed two-step model of DNA end resection, we 
hypothesized that the recruitment of EXO1 to DSBs would depend on the 
initial processing by MRN and CtIP. Since endogenous levels of EXO1 are 
undetectable by direct immunostaining (El-Shemerly et al, 2005), we 
examined EXO1 localization to laser microirradiation-induced DSBs (Bekker-
Jensen et al, 2006) using U2OS cells stably expressing GFP-tagged EXO1 
(Gravel et al, 2008). Similar to what has been previously reported, we 
observed accumulation of EXO1 at sites of DSBs (Bolderson et al, 2010) (Fig 
1A; supplementary Fig S1A, S1B). Consequently, we asked whether depletion 
of CtIP or the MRN complex (Fig 1B) would affect EXO1 recruitment to DSBs. 
Both fixed and live-cell imaging showed that depletion of either CtIP or 
MRE11 impaired the recruitment of EXO1 and RPA2 to DSBs (Fig 1C; 
supplementary Fig S1B). Furthermore, in CtIP-depleted cells we did not 
observe a delayed EXO1 recruitment at sites of damage (supplementary Fig 
S1A, S1B). In addition, downregulation of BLM did not impair EXO1 
recruitment to DSBs (data not shown). Consistent with the S/G2-specific 
recruitment of CtIP to DSBs (Sartori et al, 2007), accumulation of GFP-EXO1 
at DSBs was only observed in Cyclin A-positive cells and was strictly CtIP-
dependent (Fig 1D). Finally, EXO1, but not CtIP, failed to localize to sites of 
laser-induced DSBs in ATLD1 cells, which are deficient in DSB resection due 
to a hypomorphic mutation of the MRE11 gene (Carson et al, 2003; Stewart et 
al, 1999) (supplementary Fig S1C-E). This defect was rescued upon re-
expression of wild-type MRE11 (supplementary Fig S1F). From these 
observations, we concluded that the recruitment of EXO1 to DSBs depends 
on the initial DSB-end trimming carried out by MRN together with CtIP. 
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CtIP directly interacts with EXO1 and restrains its exonucleolytic activity 
Although independently recruited to sites of DSB (supplementary Fig S1E) 
(Chen et al, 2008; Lisby et al, 2004), CtIP was shown to interact with MRN 
and to stimulate its endonuclease activity in vitro (Sartori et al, 2007), 
indicative of a functional relationship between these two key factors during 
DNA end resection. This prompted us to examine whether EXO1 physically 
associates with the MRN-CtIP complex. To test this hypothesis, CtIP or EXO1 
were immunoprecipitated from HEK293T whole cell extracts (WCEs) and the 
recovered complexes analyzed by immunoblotting. Interestingly, CtIP, but not 
MRE11 was present in anti-EXO1-immunocomplexes both in non-stressed 
cells and in cells treated with camptothecin (Fig 2A), a chemotherapeutic 
agent known to induce DSBs exclusively during DNA replication by trapping 
DNA topoisomerase 1 cleavage complexes (Pommier, 2006). Even though we 
noticed that EXO1 preferentially interacts with the hyperphosphorylated form 
of CtIP in damaged cells (Fig 2A, lane 8), we did not observe any substantial 
differences in CtIP-EXO1 interaction upon phosphatase treatment of the CtIP-
EXO1 immunocomplex (supplementary Fig S2A). While we confirmed the 
previously reported CtIP-MRE11 interaction, we were unable to detect EXO1 
in anti-CtIP immunocomplexes, likely due to low cellular levels of EXO1 (El-
Shemerly et al, 2005). Therefore, we immunoprecipitated CtIP from HEK293T 
cells transiently expressing OMNI-tagged EXO1. Under these conditions, we 
detected EXO1 in anti-CtIP immunocomplexes, both in presence and absence 
of hydroxyurea (supplementary Fig S2B). 
To investigate whether the interaction between CtIP and EXO1 is direct or 
rather relies on additional bridging factors, we examined CtIP-EXO1 complex 
formation using purified, recombinant proteins in an anti-EXO1 
immunoprecipitation experiment (Fig 2B). Although a minor fraction of CtIP 
was unspecifically bound to beads, CtIP was clearly enriched when equimolar 
amounts of EXO1 were present (Fig 2B, lane 4), thus demonstrating that the 
two proteins are able to directly bind to each other in vitro. 
S. cerevisiae Sae2 displays endonuclease activity on defined substrates 
(Lengsfeld et al, 2007). Although a similar activity has not yet been reported 
for human CtIP, CtIP was shown to enhance the endonucleolytic activity of 
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MRE11-RAD50 complex (Sartori et al, 2007). Based on these observations, 
we addressed whether CtIP might also affect the 5’-3’ exonuclease activity of 
EXO1 in vitro. For this purpose, we first examined the activity of purified 
recombinant EXO1 (supplementary Fig S2C) using a singly-nicked plasmid 
DNA substrate. Importantly, only wild-type EXO1, but not a catalytically-dead 
mutant, was able to completely degrade the nicked strand within 30 minutes 
of incubation, indicating that our preparation was devoid of contaminant 
exonuclease activities (supplementary Fig S2D). Remarkably, the addition of 
equimolar amounts of CtIP decreased exonucleolytic processing, while it did 
not inhibit the activity of E. coli exonuclease III (Fig 2C). Under similar assay 
conditions, MRE11-RAD50 did not substantially affect EXO1 activity 
(supplementary Fig S2E). In addition, we observed a similar inhibitory effect of 
CtIP on EXO1 activity using either a radiolabelled DNA oligonucleotide 
substrate (Fig 2D) or a linearized plasmid (Fig. 2E) both containing 3'-
overhangs, the preferred substrate for EXO1 in vitro (supplementary Fig S2G) 
(Lee & Wilson, 1999). Electrophoretic mobility shift assays showed that, in 
contrast to EXO1, CtIP did not efficiently bind to the oligonucleotide substrate 
(supplementary Fig S2F), excluding the possibility of a non-specific inhibition 
of EXO1 by CtIP through steric hindrance. As observed with the nicked 
plasmid, CtIP did not inhibit the activity of E. coli exonuclease III on the linear 
substrate (data not shown). Moreover, neither MRE11-RAD50 nor BLM 
affected EXO1 activity on the plasmid with 3'-overhangs (supplementary Fig 
S2H). Interestingly, pre-incubation of CtIP with either blunt-ended or 5'-
overhang substrates somehow facilitated processing by EXO1, compared to 
the situation in which the proteins were added in the reversed order 
(supplementary Fig S2I).  
The evidence obtained from these biochemical data may suggest that CtIP is 
potentially able to restrain long-range resection by EXO1, thereby generating 
appropriate recombinogenic ssDNA structures (Mimitou & Symington, 2009; 
Niu et al, 2009). Inhibition of EXO1 activity was also reported during repair of 
DNA mismatches. However, while in mismatch repair RPA (Genschel & 
Modrich, 2009) or possibly MutLα (Zhang et al, 2005) are required for 
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terminating EXO1 activity upon removal of the mismatch, our data suggest 
that CtIP may act to fine-tune the nucleolytic activity of EXO1. 
 
CtIP and EXO1 promote resistance to camptothecin and prevent 
genomic instability  
Our observations indicate that the initial end-trimming activity of MRN-CtIP is 
required for the recruitment of EXO1 to sites of DNA damage and that CtIP 
may subsequently control EXO1 exonucleolytic activity to facilitate HR. This 
prompted us to examine whether some of the phenotypes reported for CtIP-
deficient cells in response to camptothecin require EXO1 (Sartori et al, 2007). 
To this end, we employed siRNA-mediated downregulation of CtIP and EXO1 
and monitored various DNA damage phenotypes in response to 
camptothecin. Importantly, single or combined depletion of CtIP and EXO1 did 
not significantly affect transition through S-phase, as judged by flow cytometry 
and incorporation of 5-ethynyl-2'-deoxyuridine in DNA (supplementary Fig 
S3A, S3B). As previously shown, CtIP knock down led to a decrease in CHK1 
and RPA2 phosphorylation (supplementary Fig S3C), indicative of inefficient 
resection and impaired ATR activation (Sartori et al, 2007). On the other 
hand, EXO1 depletion had no major impact on ATR signaling, apart from a 
modest increase in RPA2 hyperphosphorylation (supplementary Fig S3C). 
Moreover, the pattern of camptothecin-triggered DNA damage signaling 
events in cells simultaneously depleted for CtIP and EXO1 did not vary from 
that of CtIP singly-depleted cells (supplementary Fig S3C). Taken together, 
these data strengthen the view that EXO1 acts downstream of CtIP and MRN 
in DNA end resection and are consistent with studies reporting an alternative, 
EXO1-independent mode of processive resection (Gravel et al, 2008; Mimitou 
& Symington, 2008). 
Next, we analyzed the sensitivity of these cells to an acute treatment with 
camptothecin by colony formation assays. Consistent with previous reports, 
we found that CtIP downregulation caused hypersensitivity to camptothecin, 
while EXO1 depletion conferred only minor cytotoxicity (Fig 3A) (Gravel et al, 
2008; Sartori et al, 2007). Interestingly, we observed a partial, but statistically 
significant rescue of sensitivity at low camptothecin concentrations by 
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simultaneous downregulation of CtIP and EXO1 (Fig 3A, 3B). Consistent with 
this, we monitored a similar increase in survival upon chronic treatment with 
camptothecin (Fig 3C). To extend our observations we treated cells with 
Olaparib, an inhibitor of poly(ADP-ribose) polymerase (PARP) (Helleday et al, 
2008). Since PARP is involved in the repair of DNA single strand breaks 
(SSBs) (Hoeijmakers, 2001), it was proposed that PARP inhibition results in 
the accumulation of replication-associated DSBs (Bryant et al, 2005; Farmer 
et al, 2005), thus creating lesions similar to those caused by camptothecin 
(Pommier, 2006). Ultimately, treating singly- or doubly-depleted cells with 
Olaparib resulted in a pattern of hypersensitivity similar to that of 
camptothecin (supplementary Fig S3D).  
Thus far, we conclude from our data that CtIP and EXO1 act in the same 
pathway, but they also point to a potentially novel genetic interdependency 
between these two factors during the repair of replication-associated DSBs. 
To gain further, structure-based insight into the repair of camptothecin-
induced lesions, we analyzed metaphase spreads from cells lacking CtIP and 
EXO1. Compared to control cells, we observed that EXO1-deficient cells 
displayed a slight increase in broken chromatids, while depletion of CtIP led to 
a reduction of this type of chromosomal aberrations (supplementary Fig S3E). 
Interestingly, however, we noticed a significant increase of radial 
chromosomes specifically in doubly-depleted cells, indicative of repair by 
illegitimate end-joining of DSBs (Fig 3D; supplementary Fig S3F). 
 
CtIP and EXO1 cooperate to prevent hazardous DNA-PK-dependent end-
joining  
It has been shown that DNA replication-associated DSBs, such as those 
induced by camptothecin, activates DNA-PKcs, judged by 
autophosphorylation on S2056 (Chen et al, 2005; Sakasai et al, 2010) 
(supplementary Fig S4A). Analyzing S2056 autophosphorylation, we 
observed increased DNA-PKcs activation particularly in doubly-depleted cells, 
and the signal was further amplified in response to camptothecin (Fig 4A). 
This prompted us to reexamine camptothecin-induced chromosomal 
aberrations upon inhibition of DNA-PKcs (supplementary Fig S4A). Under 
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these conditions we observed an almost 3-fold reduction of radial structures in 
EXO1/CtIP-deficient cells, while DNA-PKcs inhibition had no major effect in 
singly-depleted cells (Fig 4B; supplementary Fig S4B and data not shown). 
Consistently, and in agreement with an upregulation of NHEJ in absence of 
CtIP and EXO1, DNA-PKcs inhibition dramatically increased the number of 
camptothecin-induced breaks measured by PFGE (Fig 4C; supplementary Fig 
S4C).  
 
CONCLUDING REMARKS 
Taken together, our data imply that two factors involved in DNA end resection, 
CtIP and EXO1, most likely act as a unit to maintain genomic stability by 
protecting cells from the deleterious consequences of end-joining-mediated 
repair of camptothecin-induced DNA lesions. A similar scenario was reported 
for the repair defects in Fanconi anemia cells (Adamo et al, 2010; Pace et al, 
2010). Therefore, we speculate that hypersensitivity to replication-associated 
DSBs in resection-compromised cells is most likely the result of inappropriate 
NHEJ rather than HR-deficiency per se. 
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METHODS 
 
Live cell imaging and laser micro-irradiation - DSBs were generated in the 
nuclei of living cells on 18 mm glass cover slips by micro-irradiation of 
arbitrarily shaped regions of interest (ROI) at 355 nm with 15 mW output 
power of the laser (Genesis 355-80, Coherent Inc.) (Walter et al, 2003). ROIs 
were irradiated for 10 consecutive times and identical ROIs were used in all 
experiments. Subsequently, fluorescence time-lapse imaging was performed 
for GFP (488 nm excitation, 525-560 nm emission; SP5, Leica, Mannheim, 
Germany) using a HCX Plan-Apo 63X/NA 1.40 oil immersion objective. Pre-
sensitization with 10 µM bromodeoxyuridine (BrdU) was used to avoid 
artifacts by high local density of DSBs. Non pre-sensitized, control cells 
showed lack of EXO1 and CtIP recruitment under the same settings. Cells 
were kept in complete growth medium under 5% CO2 at 37°C during the 
experiments. 
For fixed cell imaging, DSBs in defined nuclear volumes were generated by 
micro-irradiation (MMI CellCut) with a 355 nm UV-A laser adjusted at 50% of 
the power. Prior to irradiation, cells were grown for 24 h in the presence of 10 
µM BrdU. 
 
Cell culture and transfections - HEK293T cells were maintained as 
described (El-Shemerly et al, 2005). Human U2OS osteosarcoma cells and 
U2OS cells stably expressing GFP-HA-EXO1 (kindly provided by S. P. 
Jackson, University of Cambridge, UK) were cultured in DMEM supplemented 
with 10% fetal calf serum, standard antibiotics and G-418 (0.5 mg/ml). 
Immortalized ATLD1 cells transduced with retrovirus expressing the wild-type 
MRE11 cDNA (ATLD1/MRE11) or retrovirus harboring the empty vector 
(ATLD1/vector) (a kind gift of M. Weitzman, Salk Institute, S. Diego, CA) were 
grown in DMEM supplemented with 20% FCS, streptomycin/penicillin (100 
U/ml) and 1 µg/ml puromycin (Sigma). GFP-EXO1 (kindly provided by F. 
Marini, University of Milano, Italy) was transiently transfected in ATLD1 cells 
using Fugene HD (Roche). 
All siRNA duplexes were purchased from Microsynth (Switzerland) with the 
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exception of MRE11 siRNA, which was purchased from Dharmacon (USA). 
siRNA sequences are as follow: Luciferase (siCNTL) 
(CGUACGCGGAAUACUUCGATT) (Sartori et al, 2007), CtIP 
(GCUAAAACAGGAACGAAUCTT) (Sartori et al, 2007), EXO1  
(CAAGCCUAUUCUCGUAUUUTT) (Gravel et al, 2008), and MRE11 
(GAGCAUAACUCCAUAAGUATT) (Adams et al, 2006). siRNA duplexes were 
transfected into cells using Lipofectamine RNAiMAX (Invitrogen) in two 
consecutive rounds to a final concentration of 80 nM as follows: control (80 
nM luciferase siRNA), EXO1 (40 nM EXO1 siRNA + 40 nM control siRNA), 
CtIP (40 nM CtIP siRNA + 40 nM control siRNA), or combined EXO1 and CtIP 
(40 nM EXO1 siRNA + 40 nM CtIP siRNA). Experiments were typically 
performed 72h.  
 
Antibodies and chemicals - Antibodies were purchased from S. Cruz 
Biotech. (goat polyclonal anti-CtIP and anti-OMNI, mouse monoclonal anti-
CHK1 and anti-GFP, rabbit polyclonal anti-Cyclin A); Sigma (mouse 
monoclonal anti-beta-tubulin and anti-FLAG); Cell Signaling Tech. (rabbit 
monoclonal anti-γH2AX and anti-CHK1-pS345); Upstate Biotech. Inc. (mouse 
monoclonal anti-γH2AX); Novus Biologicals (rabbit polyclonal anti-MRE11); 
GeneTex (mouse monoclonal anti-MRE11); Calbiochem (mouse monoclonal 
anti-RPA2); NeoMarkers (mouse monoclonal anti-EXO1); Abcam (rabbit 
polyclonal anti-pS2056-DNA-PKcs); or described previously (rabbit polyclonal 
anti-EXO1, F-15) (El-Shemerly et al, 2005) 
Polyclonal and mouse monoclonal anti-CtIP antibodies (Sartori et al, 2007) 
were provided by R. Baer (Columbia University, New York, NY). Secondary 
HRP-conjugated anti-mouse and anti-rabbit antibodies were form GE-
Healthcare and the HRP-conjugated anti-goat was from S. Cruz Biotech. 
Alexa Fluor-488, -594, and -647-conjugated secondary antibodies were from 
Invitrogen. 
Camptothecin (Sigma) and AZD2281 (Olaparib, Selleck Chemicals) were 
dissolved in DMSO at 1 mM and 10 mM stock concentrations, respectively. 
Hydroxyurea (Sigma) was dissolved in water at 1 M stock concentration. EdU 
(5-ethynyl-2'-deoxyuridine) was from Invitrogen. The DNA-PKcs inhibitor 
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NU7441 (Tocris Bioscience) (Leahy et al, 2004) was dissolved in DMSO at 5 
mM stock concentration. The E. coli exonuclease EXOIII was from New 
England Biolabs. 
 
Immunofluorescence staining and analyses - Cells grown on cover slips 
were either fixed directly in ice-cold methanol for 15 min or pre-extracted for 5 
min on ice using 25 mM HEPES pH 7.4, 50 mM NaCl, 1 mM EDTA, 3 mM 
MgCl2, 300 mM sucrose and 0.5% Triton X-100 before fixation in 4% 
formaldehyde (w/v) in PBS for 15 min at room temperature (RT). Cover slips 
were incubated overnight at 4 °C with primary antibodies and Alexa–
conjugated secondary antibodies for 1h at RT. The cover slips were mounted 
with Vectrashield® (Vector Laboratories) containing DAPI. Images were 
acquired either using a Leica confocal SP2 or an Olympus IX81 fluorescence 
microscope. 
 
Western blotting and Immunoprecipitation – Cells lysis, 
immunoprecipitation and immunoblot analysis were performed as described 
previously (El-Shemerly et al, 2008). To ensure that the observed interactions 
were not DNA-mediated, ethidium bromide was included in all samples. 
 
In vitro protein interaction - 200 ng of purified, recombinant CtIP (Sartori et 
al, 2007) and EXO1 (El-Shemerly et al, 2005) were incubated either alone or 
together for 30 min at 4 oC in 1 ml TNE buffer containing 50 mM Tris-HCl, pH 
7.5, 140 mM NaCl, 1 mM EDTA and 10 µg/ml BSA. Proteins were 
immunoprecipitated with the antibody F-15 for 2h at 4 oC. Protein-A 
sepharose (GE Healthcare) immunocomplexes were analyzed as described 
(El-Shemerly et al, 2005).  
 
Exonuclease assays - The nicked substrate was generated by incubating the 
pGEM-13Zf(+) plasmid derivative with N.BstNBI (Fischer et al, 2007) and 
purified by gel extraction (Qiagen). Exonuclease activities were assayed in a 
buffer containing 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 2 mM MgCl2, 1 mM 
DTT and 0.1 mg/ml BSA. Where indicated, final concentrations of purified 
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recombinant proteins were as follows: 15 nM EXO1, 15 nM CtIP and 300 nM 
RPA. Notably, the presence of purified RPA in the reaction resulted in a 
defined pattern of nucleolytic processing (Fig 2B) as compared to reactions 
without RPA (supplementary Fig 2E). Reactions were stopped by incubation 
in 10 mM EDTA, 0.25 % SDS and 100 µg/ml Proteinase K for 10 min at 37° 
C. DNA products separated on 0.8% agarose were stained with either 
ethidium bromide or SYBR Gold and analyzed with a Typhoon 
PhosphorImager (GE Healthcare). 
Hairpin exonuclease assays were performed in 20 µl with 1 nM DNA 
substrate (annealed 3’ labeled HL1: 5’-
TCATTGCCTATCCTGACAGTCCGACACATCGGACTGTCAGGATAGGCAA
TGATCTTTTTTTTT -3’), 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 5 mM MgCl2, 
1 mM DTT and 50 ng/µl BSA at 37oC with the indicated protein concentrations 
and time-points. Reactions were terminated by addition of an equal volume of 
99% (v/v) formamide 0.1% (w/v) bromophenol blue and heating at 95°C for 5 
min. Products were resolved by electrophoresis in 15% (w/v) polyacrylamide 
gel containing 8 M urea (acrylamide/bis-acrylamide 19:1) run in 1xTBE buffer 
at 25 mA. Gels were dried and analyzed with a Typhoon PhosphorImager (GE 
Healthcare). 
Linearized plasmids were generated by incubating the pGEM-13Zf(+) plasmid 
derivative with either BanII (5' overhangs), HindIII (3' overhangs) or ScaI 
(blunt ends) followed by column purification (Qiagen). Proteins used in the 
assay were mixed and incubated on ice prior to addition into reaction tubes 
containing 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 2 mM MgCl2, 1 mM DTT and 
0.1 mg/ml BSA. DNA products were separated as described above. 
 
DNA-Binding assays - Gel mobility shift assays were performed in a volume 
of 20 µl containing 5 nM of annealed 5' labeled HL1, 50 mM Tris-HCl pH 7.5, 
50 mM NaCl, 1 mM EDTA, 1 mM DTT, 50 ng/µl BSA. The reactions were pre-
incubated with the corresponding proteins, 10 nM EXO1, 50 nM CtIP for 15 
min at RT before addition of the substrate and further incubated for 60 min. 
After addition of glycerol to a final 10% concentration, separation was 
Results 
 
 
 52 
performed in a 6% (w/v) native polyacrylamide gel run in 1xTBE buffer at 25 
mAmp. Gels were analyzed as described above. 
 
Pulse-field gel electrophoresis - Subconfluent cultures of U2OS were mock-
treated (DMSO) or camptothecin-treated for 4h. Cells were harvested by 
trypsinization, and agarose plugs of 106 cells were prepared in a disposable 
plug mold (BioRad). Plugs were then incubated in lysis buffer (100 mM EDTA, 
1% (w/v) sodium lauryl sarcosyl, 0.2% (w/v) sodium deoxycholate, 1mg/ml 
proteinase K) at 37 oC for 72h. Plugs were then washed four times in 20 mM 
Tris-HCl pH 8.0, 50 mM EDTA before loading onto an agarose gel. 
Electrophoresis was performed for 23h at 14 oC in 0.9% (w/v) Pulse Field 
Certified Agarose (BioRad) containing Tris-borate/EDTA buffer according to 
the conditions described in (Hanada et al, 2007) and adapted to a BioRad 
CHEF DR III apparatus. The gel was then stained with ethidium bromide and 
analyzed using an Alpha Innotech Imaging system. 
 
Colony formation assay - Cells were either mock-treated (DMSO) or treated 
with the indicated doses of camptothecin 72h after the first siRNA 
transfection. The drug was removed 1h upon treatment and cells were 
cultured for 10–14 days at 37°C. For the PARP-inhibitor AZD2281, continuous 
exposure to the compound was ensured by a first addition 72h after the 
siRNA transfection, and a second addition 72 h after the first. Colonies were 
stained with a crystal violet/ethanol (0.5%/20%) solution and counted. 
 
Chromosome analysis - After treatment with camptothecin, cells were 
allowed to recover for 8h in complete medium before chromosome 
preparation. Caffeine (2 mM) was added for the last 5h to override the G2/M 
checkpoint, and colcemid (0.1 mg/ml) was added for the last 3h to arrest cells 
in metaphase. Metaphase chromosomes were stained with DAPI. 
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FIGURE LEGENDS 
 
Figure 1 - EXO1 localization to sites of DNA damage requires both CtIP 
and MRE11  
(A) U2OS cells stably expressing GFP-EXO1 were microirradiated and 30 min 
later fixed, co-immunostained with γ-H2AX and RPA2 antibodies and 
analyzed by fluorescence microscopy. Nuclei were visualized with DAPI.  
(B) GFP-EXO1 cells were transfected with Luciferase- (CNTL), CtIP-, or 
MRE11-specific siRNA oligonucleotides and grown for 72h. Protein 
expression was examined by immunoblot using the indicated antibodies.  
(C) siRNA-transfected GFP-EXO1 cells from (B) were microirradiated, fixed 
and analyzed as in (A). 
(D) GFP-EXO1 cells treated as in (A) were co-immunostained with γ-H2AX, 
Cyclin A and CtIP antibodies. γ-H2AX positive cells were quantified for EXO1, 
Cyclin A and CtIP staining. 50 cells per sample were counted in two 
independent experiments. 
 
Figure 2 - CtIP interacts with EXO1 and restrains its exonucleolytic 
activity  
(A) WCEs (5 mg) from mock or camptothecin-treated (1 µM, 1h) HEK293T 
cells were immunoprecipitated with preimmune serum (PI), anti-CtIP or anti-
EXO1 polyclonal antibodies. Proteins were detected by immunoblot with the 
indicated antibodies. For CtIP, short (S) and long (L) exposure times are 
shown. Arrows indicate the hyperphosphorylated form of CtIP. The membrane 
was stripped and re-probed using a monoclonal anti-EXO1 antibody. Input = 
1% of the WCEs used for IP.  
(B) Purified, recombinant EXO1 (200 ng) and FLAG-tagged CtIP (200 ng) 
were incubated either alone or together before immunoprecipitation with an 
anti-EXO1 antibody. Proteins were visualized with the indicated antibodies. 
Recombinant EXO1 (50 ng, lane 1) and FLAG-CtIP (20 ng, lane 5) were 
loaded as inputs. 
(C) Nicked plasmid (3.75 nM) was incubated with EXO1 (15 nM) or EXOIII (10 
U) in the presence or absence of CtIP (15 nM). RPA (300 nM) was present 
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were indicated. Products were resolved as described in Methods. The 
migration patterns of the double-stranded, nicked plasmid and of the single-
stranded product are indicated.  
(D) Radiolabelled oligonucleotide (1 nM, lane 1) was incubated with CtIP 
alone (1 nM, lane 2), EXO1 alone (1 nM, lanes 3-7) or both together at 
equimolar concentrations (lanes 8-12). Reactions were terminated at the 
indicated time-points and the products were analyzed as described in 
Methods. 
(E) Linearized plasmid with 3'-overhangs (2.5 nM, 5 nM DNA ends) was 
incubated at 37°C with hEXO1 (15 nM), RPA (300 nM) and the indicated 
amounts of CtIP. Reactions were terminated at the indicated time-points and 
the products were analyzed as described in Methods. 
 
Figure 3 - CtIP and EXO1 protect cells from chromosomal damage  
(A) 72h after the transfection with the indicated siRNA oligonucleotides, U2OS 
cells were treated with either DMSO or camptothecin (1h, 1 µM; acute 
treatment) and survival was determined by colony formation. Data represent 
the mean ± standard error of the mean (SEM) of five independent 
experiments. 
(B) Cell survival at low doses of camptothecin from the data shown in (A). 
Data represent the mean ± standard error of the mean (SEM) of five 
independent experiments 
(C) Cells transfected as in (A) were treated with either DMSO or camptothecin 
for 24h (chronic treatment) and survival was determined by colony formation. 
Data represent the mean ± SEM of three independent experiments. 
(D) Metaphase spreads from cells transfected and treated as described in (A) 
were analyzed for chromosomal aberrations. 50 metaphase spreads were 
analyzed for each sample. The percentages of metaphase spreads displaying 
the indicated numbers of radial chromosomes are shown. 
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Figure 4 - Inhibition of DNA-PKcs rescues radial chromosomes 
formation 
(A) U2OS cells transfected with siRNA oligonucleotides were treated with 
DMSO or camptothecin (1 µM, 1h) and DNA-PKcs autophosphorylation at 
S2056 was monitored. 
(B) Metaphase spreads were generated from cells transfected as in (A) and 
treated with camptothecin (1 µM, 1h) in the presence or absence of NU7441 
(10 mM). In total more than 100 spreads were analyzed for both conditions in 
two independent experiments. The average of radial chromsomes per spread 
was 1.65 (DMSO) and 0.59 (NU7441), equivalent to a 2.8-fold reduction in 
radial formation. 
(C) Cells transfected as in (A) were treated with DMSO or camptothecin (2.5 
µM, 4h) in the presence or the absence of NU-7441 (10 mM). The amount of 
broken DNA was assessed by PFGE. 
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SUPPLEMENTAL FIGURE LEGENDS 
 
Supplementary Figure S1 - CtIP- and MRN-dependent recruitment of 
EXO1 to DSBs  
 (A) Recruitment of GFP-EXO1 to laser lines visualized by fluorescence 
microscopy at early (5 min) and late (240 min) time points. 
(B) Live cell imaging of microirradiated GFP-EXO1 cells transfected with 
control (CNTL), CtIP or MRE11 siRNA. Scale bar = 10 mm. 
(C-E) CtIP recruitment to DSBs in ATLD1 cells is insufficient for DNA end 
resection. MRE11-deficient ATLD1 fibroblasts, stably transfected with an 
empty vector or with a vector directing the expression of full-length MRE11, 
were treated with camptothecin (1 µM, 1 h) and analyzed by immunoblotting 
with the indicated antibodies (C). The same pair of cells was microirradiated, 
fixed after 30 min and co-stained with either γ-H2AX and RPA2 (D) or gH2AX 
and CtIP (E) antibodies. Nuclei were visualized with DAPI.  
(F) Live cell imaging of vector- or wild-type MRE11-complemented ATLD1 
fibroblasts, transiently transfected with GFP-EXO1 and microirradiated. 
 
 
Supplementary Figure S2 - Biochemical characterization of the EXO1-
CtIP interaction  
(A) WCEs (5 mg) from DMSO or camptothecin-treated (2h, 2.5 µM) HEK293T 
cells were immunoprecipitated using an anti-EXO1 antibody. 
Immunocomplexes bound to sepharose beads were incubated with 10 units of 
calf intestinal phosphatase (CIP) for 10 min at 37 oC, washed with 3x 1ml 
TNET buffer (El-Shemerly et al, 2005), resolved by SDS-PAGE and analyzed 
by immunoblotting. 
(B) WCEs (5 mg) from HEK293T cells overexpressing OMNI-tagged EXO1, 
treated or not with hydroxyurea (2 mM, 16h) were immunoprecipitated with PI 
serum or an anti-CtIP antibody. Proteins were detected by immunoblotting 
with the indicated antibodies. 
(C) Human recombinant EXO1wt and the catalytically-dead mutant EXO1D173A 
were expressed and purified as described (El-Shemerly et al, 2005). Peak 
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fractions from the chitin affinity column were pooled, loaded on a Hi-Trap SP-
FF (1 ml) cartridge and proteins eluted with a linear salt gradient (0.0 - 0.5 M 
NaCl). Aliquots of the load (L, 5 ml), flow-through (FT, 5 ml), wash (W, 5 ml) 
fractions and of the OD280 peak (20 ml) were resolved by 8% SDS-PAGE and 
stained with Coomassie brilliant blue. 
(D) Purified wild-type EXO1 (15 nM; lanes 1-7) or catalytically-dead EXO1 
(D173A, 15 nM; lanes 9-15) were incubated with 5 nM N.BstNBI-digested 
pGEM-13Zf(+) plasmid for the indicated time points and the products resolved 
on a 0.8% agarose gel before ethidium bromide staining. 
(E) Gel-purified pGEM-13Zf(+)-nicked plasmid substrate (3.75 nM) was 
incubated at 37°C for the indicated time periods with purified EXO1 (15 nM) in 
the presence or absence of purified CtIP (15 nM) or MRE11-RAD50 (15 nM). 
The products were resolved as described in Supplementary Methods. 
(F) Radiolabelled oligonucleotide (5 nM) was incubated for 60 min at room 
temperature with purified EXO1 (10 nM), CtIP (50 nM) or both together in a 
buffer containing 1 mM EDTA. The products were analyzed as described in 
Supplementary Methods. The migration patterns of free and EXO1-bound 
oligonucleotide are indicated. 
(G) Purified linearized pGEM-13Zf(+) plasmid (2.5 nM, 5 nM DNA ends) 
containing either 3' overhangs, 5' overhangs or blunt ends was incubated for 
30 min at 37°C with EXO1 (15 nM) in the presence or absence of RPA (300 
nM) as indicated. The products were resolved as described in Supplementary 
Methods. 
(H) Purified linearized pGEM-13Zf(+) plasmid containing 3' overhangs (2.5 
nM, 5 nM DNA ends) was incubated at 37°C with EXO1 (15 nM) in the 
presence of RPA (300 nM) and either CtIP (15 nM), MRE11-RAD50 (15 nM) 
or BLM (15 nM). The products were resolved as described in Supplementary 
Methods. 
(I) Purified linearized pGEM-13Zf(+) plasmid (2.5 nM, 5 nM DNA ends) 
containing either blunt ends or 5' overhangs was incubated at 37°C with 
EXO1 (15 nM) in the presence of RPA (300 nM) or pre-incubated with either 
EXO1 (15 nM) or CtIP (15 nM) for 5 min at RT, followed by addition of CtIP or 
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EXO1, respectively. The products were resolved as described in 
Supplementary Methods. 
 
 
Supplementary Figure S3 - Effect of CtIP, EXO1 or CtIP/EXO1 
downregulation on genome stability   
(A) 72h after the transfection with the indicated siRNA oligonucleotides U2OS 
cells were subjected to propidium iodide (PI) staining for cell cycle analysis. 
(B) U2OS cells grown on glass cover slips and transfected as described in (A) 
were incubated for 20 min with 10 µM EdU (5-ethynyl-2'-deoxyuridine). 
Immediately after fixation with 4% formaldehyde cover slips were processed 
following manufacturers instructions (Invitrogen). At least 150 cells were 
counted for each condition. Percentages indicate the number of EdU-positive 
cells.  
(C) 72h after the transfection with the indicated siRNA oligonucleotides U2OS 
cells were treated with either DMSO or camptothecin (1h, 1 µM). WCEs were 
analyzed by immunoblot (left panel) or immunoprecipitation (right panel) with 
the indicated antibodies. 
(D) Cells transfected as described in (A) were treated with the indicated doses 
of AZD2281 (Olaparib) and survival was determined by colony formation. 
Data represent the mean ± SEM of three independent experiments. 
(E) Cells transfected as in (A) were treated with camptothecin (1 µM, 1h) and 
allowed to recover for 8h in complete medium before chromosome 
preparation. Caffeine (2 mM) was added for the last 5h to override the G2/M 
checkpoint, and colcemid (0.1 mg/ml) was added for the last 3h to arrest cells 
in metaphase. 50 metaphase spreads were analyzed for each sample. The 
percentages of metaphase spreads displaying the indicated numbers of 
broken chromosomes are shown. 
(F) Representative images of chromosomal abnormalities detected in 
metaphase spreads of camptothecin treated cells: broken chromatids 
(arrowheads); radial chromosomes (ellipses). Scale bar, 10 µm. 
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Supplementary Figure S4 - Inhibition of DNA-PKcs rescues 
camptothecin-induced radials formation in CtIP/EXO1 depleted cells  
(A) WCEs obtained from U2OS that were treated with camptothecin (1h, 1 
mM) in the presence or the absence of NU7441 (10 mM), were analyzed by 
immunoblot with the indicated antibodies. Autophosphorylation at S2056 was 
use as read-out for inhibition of DNA-PKcs activity by NU7441.  
 (B) 72h after the transfection with the indicated siRNA oligonucleotides, 
U2OS cells were treated with DMSO or camptothecin (2.5 µM, 4h) in the 
presence or the absence of the DNA-PKcs inhibitor NU7441 (10 mM). 
Representative images of chromosomal abnormalities detected in metaphase 
spreads are shown. Radial chromosomes (ellipses) and broken chromatids 
(arrowheads) are indicated. 
(C) Cells transfected as in (B) were treated with DMSO or camptothecin (1h, 1 
mM). The amount of broken DNA was assessed by PFGE as described in 
supplementary Methods. 
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2.2. Refining the interaction domain between EXO1 and CtIP 
Having found that EXO1 and CtIP interact, we set out to identify the 
interaction domain on EXO1. To this end, we generated OMNI-tagged EXO1 
deletion mutants by introducing a stop codon at different positions in EXO1 
using the QuickChange® mutagenesis kit (Stratagene). Briefly, we transiently 
transfected HEK 293T cells with an OMNI-tagged full-length EXO1 construct 
or with constructs encoding different OMNI-tagged EXO1 deletion mutants. 
We immunoprecipitated CtIP using a rabbit polyclonal antibody and detected 
the OMNI-tagged EXO1 proteins with a monoclonal antibody against EXO1 
that recognizes a N-terminal epitope present in all deletion mutants. The data 
showed that OMNI-EXO1 and CtIP could be recovered as a complex in all 
cases examined (Figure 10), thus not allowing us to identify the exact domain 
in EXO1 that mediates interaction with CtIP. However, in the case of the 
smallest fragment examined (EXO11-348) we were not able to draw a definite 
conclusion since this mutant runs at the same molecular size as the heavy 
chain (IgG(H)) of the antibody used for the immunoprecipitation and it is 
therefore masked by the more abundant IgG(H). Thus, more work will be 
needed to nail down the domain in EXO1 mediating interaction with CtIP. One 
possible approach will be to pull-down OMNI-tagged EXO1 (which also 
contains a His-tag) using Nickel beads to avoid using an antibody for the 
immunoprecipitation. 
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Fig. 10 
Co-immunoprecipitation experiment to map the interaction domain between EXO1 and CtIP. HEK 
293T cells were transfected with OMNI-tagged full-length or deletion mutant EXO1 constructs. CtIP was 
immunoprecipitated using a rabbit polyclonal antibody. The recovered protein complexes were resolved 
by SDS-PAGE and proteins were detected by immunoblotting using specific antibodies. 2% of the 
WCEs used for the immunoprecipitation were loaded as input. The membrane was first probed with a 
mouse monoclonal antibody against the N-terminus of EXO1, then stripped and re-probed with a mouse 
monoclonal antibody against CtIP. 
 
 
 
2.3. Identification and functional evaluation of novel 
interacting partners of EXO1 
 
2.3.1. Cloning Strep-tagged EXO1 and validating the system 
DNA-damage signaling and repair is a complex process involving a myriad of 
different proteins and effectors. EXO1 plays a well established role in the 
context of DNA repair. In order to identify novel interaction partners of EXO1 
that could be potentially involved in DNA-damage repair and signaling, we 
performed a large-scale mass spectrometry (MS) analysis. To this end, we 
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cloned full-length EXO1 into a plasmid containing a Strep-tag coding 
sequence 3' to the multiple cloning sites, such that the fusion protein 
generated upon transcription/translation features a Strep-tag at its C-terminus. 
Several clones were screened by colony-PCR, and only positive clones were 
further considered. Three positive clones were picked and their plasmids were 
sequenced to confirm both the presence and the integrity of the EXO1-Strep-
tag sequence. Plasmid DNA from these clones were extracted, amplified and 
used to transfect HEK 293T cells. The extent of Strep-EXO1 expression was 
visualized by immunoblotting. The colony designated C10 showed the highest 
expression levels of Strep-EXO1 and was the one used for all subsequent 
experiments (Figure 11, lane 6). 
 
 
 
Fig. 11 
Validation of Strep-EXO1 expression. HEK 293T cells transfected with a Mock plasmid (lane 3) or 
with DNA extracted from the three different positive clones C7, C9, and C10 (lanes 4,5 and 6), 
respectively. 50 µg of whole cell extract (WCE) were resolved on SDS-PAGE gel and proteins were 
detected by immunoblotting using specific antibodies. Human recombinant EXO1 expressed and 
purified from E.coli was loaded (100 ng, lane 1) as a control for the molecular size. 
 
In order to validate our Strep-EXO1 expression system, we first ensured that 
overexpression of the fusion protein in cells did not result in artificial 
interactions, but would be a reliable tool to detect novel EXO1 interacting 
proteins. To this end, we examined both a known EXO1 interactor, namely 
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CtIP (Eid et al. 2010), and a protein that is known not to interact with EXO1, 
namely MRE11 (Eid et al. 2010). In addition, we enclosed TRIM27 in this 
analysis, a protein that functionally interacts with EXO1 according to evidence 
that was recently obtained in our laboratory. 
To conduct these experiments, HEK 293T cells were transfected with either 
empty plasmid (Mock) or the plasmid coding for Strep-EXO1, Strep-pull down 
was performed and protein complexes resolved by SDS-PAGE were 
transferred to a PVDF membrane. Membranes were probed with specific 
antibodies to assess the presence of EXO1 interacting proteins. The data 
confirmed the presence of the established EXO1 interactor CtIP and absence 
of non-interacting protein MRE11. Interestingly, we could exclusively detect 
TRIM27 in the Strep-EXO1 pull-down but not in the Mock (Figure 12 lane 1 
vs. lane 2), thus successfully identifying TRIM27 as novel EXO1 interactor. 
 
 
Fig.12 
 Reliability of the Strep-EXO1 system to the identification of novel interacting partners. HEK 293T 
cells were transfected with either empty vector (Mock) or the Strep-EXO1 construct. A Strep-pull down 
was performed as explained in Materials and Methods. Eluted proteins were resolved on 8% SDS 
polyacrylamide gel, proteins were transferred to PVDF and detected by immunoblotting using specific 
antibodies. 2% of WCE were loaded as input.  
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2.3.2. Large scale Strep-tagged EXO1 pull-down 
Having validated the Strep-EXO1 expression system, HEK 293T cells were 
transfected with either Strep-EXO1 or empty vector. Pull-down studies were 
performed on whole cell extracts (WCE) using Strep-Tactin sepharose beads. 
Strep-EXO1 was eluted from the beads under mild conditions using D-
desthiobiotin, an agonist that binds to Strep-Tactin with high affinity, hence 
eluting Strep-tagged EXO1 together with its bound proteins. In order to check 
for the Strep-EXO1 expression and pull-down, a fraction of the eluates were 
run on a 4-15% gradient SDS polyacrylamide gel and proteins were visualized 
by silver staining. The staining showed that Strep-EXO1 was successfully 
pulled-down from cells transfected with Strep-EXO1 but not from mock-
transfected cells (Figure 13). 
 
 
Fig. 13 
Silver-stained gradient SDS polyacrylamide gel. Upon Strep-pull down from extracts of mock- or 
Strep-EXO1-transfected HEK 293T cells, proteins were eluted and 1% of each eluate was analyzed on 
a 4-15% gradient polyacrylamide gel that was silver stained. The arrow points to Strep-EXO1. 
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2.3.3. First mass spectrometry 
Proteins eluted from Strep-Tactin beads were precipitated using TCA as 
described in Materials and Methods and analyzed by mass spectrometry (MS) 
using an LTQ Orbitrap Velos (Thermo Scientific). The data obtained were 
used for performing a BLAST search against the human subset of the protein 
sequence database Swiss-Prot. Table1 shows a selection of the proteins 
found to interact with EXO1. 
 
2.3.4. Second mass spectrometry  
Having found interesting interactors of EXO1 under basal conditions in our 
first MS analysis, we performed a second MS analysis in which we aimed at 
the following: (i) confirming the hits obtained in the previous experiment; (ii) 
checking for potential interactors in cells treated with DNA damaging agents, 
hence increasing our data output by looking at both untreated and treated 
conditions. The experiment was carried out in a similar way to the previous 
one, with the addition of two distinct DNA damage protocols. In one sample 
the cells were treated with 10 Gy of ionizing radiation (IR) and harvested after 
1h. For the second sample, cells were treated for 16h with 2mM hydroxyurea 
(HU) before harvesting. Strep pull-down was performed, a fraction of each 
eluate was resolved by SDS-PAGE and proteins were visualized by silver 
staining (Figure 14 A). To ensure that agents and conditions used did result in 
adequate DNA damage, prior to MS analysis an aliquot of each sample was 
examined for markers of DNA-damage signaling, namely the phosphorylation 
of ATM at Ser-1981 and the phosphorylation of CHK2 at Thr-68 (Figure 14 B). 
Samples for MS analysis were prepared and processed as described in the 
previous chapter. Table 1 shows a selection of proteins identified in both 
experiments. The presence of known EXO1 binding proteins among the 
selected hits, namely MSH2 (Schmutte et al. 1998), and 14-3-3 (Engels et al. 
2011), confirmed quality and reliability of the analysis. 
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Fig. 14 
 Analysis of samples submitted to mass spectrometry. (A) Silver-stained SDS polyacrylamide gel of 
Strep pull-downs from HEK 293T cells. Cells were either mock-transfected (lane1) or Strep-EXO1-
transfected and left untreated (lane2), treated with 2mM HU for 16h (lane3) or treated with 10 Gy IR 
(lane 4). 2% of the eluates were loaded on the gel. The arrow points to Strep-EXO1. (B) DNA damage 
signaling was detected upon treating cells with 2mM hydroxyurea for 16h (lane 3) or with 10 Gy ionizing 
radiation (lane 4). MRE11 served to confirm equal loading of the proteins. 
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Protein Mw Function Mock UT HU IR 
MSH2 105 kDa Mismatch 
repair 
0 55 83 60 
1433F 28 kDa Adaptor 
protein 
0 28 60 25 
1433G 28 kDa Adaptor 
protein 
7 38 80 32 
1433T 28 kDa Adaptor 
protein 
8 30 47 26 
1433Z 28 kDa Adaptor 
protein 
11 47 86 37 
1433E 29 kDa Adaptor 
protein 
18 42 115 64 
1433B 28 kDa Adaptor 
protein 
7 32 64 28 
PHF6 41 kDa Transcription
al regulator? 
1 16 16 14 
THOC4 27 kDa Transcription
al regulator? 
1 21 14 21 
CH033 25 kDa ? 1 7 9 9 
ERH 12 kDa Cell cycle? 1 6 9 8 
PRP19 55 kDa DDR and pre-
mRNA 
splicing 
0 6 4 8 
RRP5 209 kDa rRNA 
processing 
0 6 2 5 
RN138 28 kDa E3 ubiquitin-
protein ligase 
0 3 2 2 
FMR1 71 kDa mRNA 
transport 
0 4 1 4 
KI67 359 kDa Cell cycle? 0 9 15 11 
ILF3 95 kDa Transcription
al regulator? 
5 21 9 17 
 
Table 1. 
Selection of EXO1 interacting proteins identified by mass spectrometry in both experiments. The 
table shows: hit (column 1), molecular weight (column 2), annotation (column 3) number of unique 
peptides (columns 4-7) obtained in the 2nd mass spectrometry analysis from untransfected cells (Mock), 
Strep-EXO1 transfected cells that were left untreated (UT), treated with hydroxyurea (HU) or ionizing 
radiation (IR). 
 
 
Discussion 
 
 
 82 
3. Discussion 
Double strand breaks and intra-strand crosslinks are the most toxic lesions 
that may occur to DNA. The error-free repair of DNA double strand breaks by 
homologous recombination is of vital importance for cells as it allows 
preventing oncogenesis by maintaining a stable genome. At the molecular 
level, one of the first steps of homologous recombination is the resection of 
the DNA termini present at double strand breaks to expose ssDNA. This, in 
turn, is an important intermediate for RAD51-mediated strand invasion, which 
promotes sequence homology search and facilitates successful completion of 
homologous recombination. Several studies have investigated the molecular 
mechanism of DNA end resection in yeast. Collectively, these studies led to a 
two-step model of DNA resection according to which DNA is resected by MRN 
and CtIP to generate short 3’-overhangs of ssDNA, followed by a more 
extensive resection step that is executed by EXO1 or BLM and DNA2 
(Mimitou and Symington, 2008; Gavel et al. 2008; Nimonkar et al. 2011). 
Although these studies have significantly contributed to shed light on the 
overall process of homologous recombination, some specific aspects, such as 
the mechanism by which EXO1 is recruited to sites of DNA damage or the 
way the nuclease activity of EXO1 is regulated, remained elusive.  
 
In the work that I carried out during my doctoral studies and that is presented 
here, we addressed these unresolved issues. Namely, we examined whether 
EXO1 recruitment to double strand breaks would depend on MRE11 and/or 
CtIP and, if this is the case, whether any of these earlier DNA double strand 
break-recognizing proteins would affect EXO1 activity at the site of damage. 
We also decided to investigate the functional role of components of the two-
step resection model, such as MRE11, CtIP and EXO1, by examining the 
DNA damage sensitivity of cells depleted of these proteins. To carry out such 
studies, we took advantage of cell lines deficient in the expression of the 
proteins under investigation or of RNA-mediated interference of protein 
expression using specific oligonucleotides. 
On the basis of the two-step model of resection, we initially set out to examine 
whether EXO1 recruitment to double strand breaks is dependent on the initial 
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resection step carried out by MRN and CtIP. Indeed, upon depletion of either 
CtIP or MRE11, we observed both in fixed and live cell imaging an impaired 
recruitment of EXO1 to laser microirradiation-induced double strand breaks. 
Consistent with published evidence on the S/G2-specific recruitment of CtIP 
to double strand breaks (Sartori et al. 2007), we observed accumulation of 
EXO1 at these sites exclusively in cyclin A-positive cells and such recruitment 
was strictly CtIP-dependent. Furthermore, transiently transfected GFP-EXO1 
did not localize to double strand break sites in ATLD1 cells, which are 
deficient in DNA end resection due to a hypomorphic mutation of the MRE11 
gene. Accordingly, this phenotype was fully rescued upon re-expressing wild-
type MRE11 in these cells. Taken together, these data indicate that the 
physical presence of the MRN/CtIP complex and/or its enzymatic activity is 
necessary for EXO1 loading and processing of DNA ends, thus confirming the 
findings that led to the proposal of the two step model of resection and 
extending them to include evidence on the molecular mechanism of EXO1 
recruitment to sites of damage. 
 
Another point that we address in this study was the mechanism of EXO1 
regulation at the sites of double strand break. It is well established that DNA 
repair is carried out by a plethora of proteins displaying a variety of enzymatic 
activities that modify DNA prior to and during repair of damage. Since 
inappropriate recruitment or lack of regulation of the enzymatic activity of 
repair enzymes may result harmful to DNA and worsen the damage already 
present, a precise control of their timely localization and function must be put 
in place. To accomplish this, eukaryotic cells have developed sophisticated 
strategies that are based on the implementation of post-translational 
modifications (PTMs) as means to facilitate protein-protein interactions, 
allowing recruitment and activation of the right factors in the right place and at 
the right time. PTMs that play major roles in this context are phosphorylation, 
acetylation, ubiquitylation and sumoylation.  
 
Previous members of the Ferrari laboratory showed that EXO1 activity in 
mammalian cells is controlled by post-translational modifications, with ATR-
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dependent phosphorylation being a necessary and sufficient event for 
targeting EXO1 to ubiquitin-mediated degradation in cells experiencing stalled 
DNA replication (El-Shemerly et al. 2005; El-Shemerly et al. 2008). Moreover, 
Bolderson and colleagues recently showed that EXO1 undergoes 
phosphorylation in an ATM-dependent manner at sites of double strand break 
following its recruitment.  As previously demonstrated in studies that were 
conducted in yeast (Morin et al. 2008), phosphorylation could be required to 
attenuate EXO1 activity and this would in turn be a means to prevent 
excessive resection of DNA ends (Bolderson et al. 2010). 
In this work we also addressed the issue of regulation of EXO1 activity and 
provide results that suggest a novel mechanism by which EXO1 could be 
controlled at the site of the DNA damage. Our in vitro data showed a 
significant inhibition of the exonucleolytic activity of EXO1 in the presence of 
CtIP. Notably, we obtained evidence that the inhibitory effect exerted by CtIP 
was specific to EXO1, since the activity of an unrelated 5'-3' exonuclease was 
not affected by the presence of CtIP. We suggest that what we observed in 
vitro may reflect the sequence of events occurring in vivo, where a timely 
restraint of EXO1 activity could prevent the formation of excessively long 
recombination intermediates that may hamper the faithful execution of HR.  
Thus, the evidence obtained in our study, along with data published in the 
literature, highlights the concept that EXO1 nucleolytic activity is tightly 
controlled in response to DNA damage. 
 
Data obtained in cell survival assays, in which we analyzed the sensitivity of 
cells subjected to single or combined depletion of CtIP and EXO1 using 
siRNA and treated with different doses of camptothecin, further strengthen 
this concept. In agreement with other reports, we observed that CtIP depletion 
caused hypersensitivity to camptothecin (Sartori et al. 2007), whereas EXO1 
downregulation conferred minor cytotoxicity (Gravel et al. 2008). Interestingly, 
we observed a partial but statistically significant rescue of sensitivity at low 
camptothecin doses upon co-depletion of EXO1 and CtIP. One possible 
explanation for this observation could be that, upon CtIP downregulation, 
EXO1 “over-resects” DNA giving rise to faulty recombination intermediates. 
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On the other hand, depletion of both proteins avoids the deleterious effects of 
uncontrolled EXO1 resection activity, allowing survival. The latter, however, 
may come at a price if it results from inappropriate NHEJ, the consequence of 
which are gross chromosomal aberrations and the onset of cancer. 
 
In order to test this hypothesis, we analysed metaphase spreads from cells 
depleted for CtIP, EXO1 or both paying particular attention to the presence of 
radial chromosomes. We noticed a significant increase in the number of radial 
chromosomes in cells co-depleted for CtIP and EXO1, indicative of illegitimate 
repair by NHEJ. To further confirm our observation, we examined the 
activation of DNA-PKcs, a kinase that is instrumental in the process of DNA 
end ligation by NHEJ. It is known from the literature that camptothecin 
activates DNA-PKcs, as evidenced by its autophosphorylation (Sakasai et al. 
2010). Interestingly, we observed increased DNA-PKcs activation in cells co-
depleted for EXO1 and CtIP under "basal" conditions, and the signal was 
further amplified when cells were treated with camptothecin. This prompted us 
to re-examine the metaphase spreads for radial chromosome formation under 
conditions of DNA-PKcs inhibition. In this setting, we observed almost 
threefold reduction in the number of radial chromosomes in cells co-depleted 
for EXO1 and CtIP as well as an increase in broken chromatids, compared to 
cells where DNA-PKcs was not inhibited. Consistent with this, and in 
agreement with an upregulation of NHEJ in the absence of EXO1 and CtIP, 
DNA-PKcs inhibition significantly increased the number of DNA breaks 
measured by PFGE. 
 
Upon conclusion of this interesting study that highlighted the precise control of 
EXO1 recruitment and enzymatic activity by the interacting protein CtIP, we 
undertook an explorative investigation aimed at identifying novel EXO1 
interacting proteins that could be involved in DDR. This ongoing study is 
presented in the second part of the thesis as unpublished results. 
The assembly and retention of different proteins at sites of damaged 
chromatin in so-called ionizing radiation-induced foci (IRIF) is a core feature of 
the DDR. IRIF formation is often used as read-out for the activation of DDR 
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that is triggered upon detection of damage as well as for the identification of 
novel proteins participating to the DDR. Over the last decade, insights into the 
architecture of IRIF and the identity of proteins residing in them as well as the 
molecular mechanisms of their retention at these structures have been vastly 
expanded. Despite such advances, however, many studies have been simply 
descriptive, thus lacking the necessary depth that would allow appreciating in 
which specific steps of the DDR the newly identified IRIF components are 
involved. The importance of studying IRIF is underlined by the fact that 
defects in IRIF formation or loss of DDR factors that accumulate at IRIF are 
often associated with genomic instability and cancer. For instance, an 
hypomorphic mutation in NBS1 leads to Nijmegen breakage syndrome (NBS), 
which results in predisposition to cancer, immunodeficiency and growth 
retardation. Likewise, a mutation in the RNF168 has been recently linked to 
the RIDDLE syndrome whose clinical features include increased 
radiosensitivity, immunodeficiency, dysmorphic features and learning 
difficulties (Stewart et al. 2007). Though, despite the effort of revealing the 
complexity of IRIF may seem to be a daunting undertaking, it will be the only 
way to expand our knowledge of them, thus facilitating the understanding of 
mechanisms that drive oncogenesis and other pathological syndromes.  
Given these premises, we set out to identify proteins interacting with EXO1 in 
order to better understand the role and the regulation of EXO1 in DNA-end 
resection as well as to identify new factors that could have a role in IRIF 
formation. In a large-scale mass spectrometry analysis, using a tagged form 
of EXO1 we successfully identified a set of novel interacting proteins. Ongoing 
studies are clarifying whether these EXO1 partners might have a role in DNA 
repair, a finding that would enable us to shed more light on the complex 
process of DDR. 
 
In conclusion, the first part of this study describes a novel functional role for 
the interaction of two important factors involved in DNA end resection, namely 
CtIP and EXO1. The findings reported here imply that both proteins likely act 
together to influence the selection between HR and NHEJ repair pathways, 
hence protecting cells from the deleterious consequences of end-joining-
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mediated repair of double strand breaks. Based on our findings, we speculate 
that hypersensitivity to replication-associated double strand breaks in cells 
compromised for HR is probably due to inappropriate NHEJ, at least in part, 
rather than HR deficiency alone. In the second part of this study we present 
findings on novel proteins interacting with EXO1 that might have important 
roles in DDR and might, eventually, turn out to be new targets in cancer 
therapy. 
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4. MATERIALS AND METHODS 
 
Cell lines and cell culture 
293T human embryonic kidney cells were maintained in Dulbecco's modified 
Eagle's medium (DMEM; Invitrogen) supplemented with 10% fetal calf serum 
(Gibco), penicillin/streptomycin (100 U/ml; Gibco). Human U2OS 
osteosarcoma cells and U2OS cells stably expressing GFP-HA-EXO1 (kindly 
provided by S. P. Jackson, University of Cambridge, UK) were cultured in 
DMEM supplemented with 10% fetal calf serum, standard antibiotics and G-
418 (0.5 mg/ml). Immortalized ATLD1 cells transduced with retrovirus 
expressing the wild-type MRE11 cDNA (ATLD1/MRE11) or retrovirus 
harboring the empty vector (ATLD1/vector) (a kind gift of M. Weitzman, Salk 
Institute, S. Diego, CA) were grown in DMEM supplemented with 20% FCS, 
streptomycin/penicillin (100 U/ml) and 1 µg/ml puromycin (Sigma). OMNI-
EXO1 (El-Shemerly et al, 2005) was transiently transfected in 293T cells with 
Metafectene (Biontex) while GFP-EXO1 (kindly provided by F. Marini, 
University of Milano, Italy) was transiently transfected in ATLD1 cells using 
Fugene HD (Roche). For this, 1 µg of the DNA and 4 µl of the transfecting 
reagent were added to separate tubes, each containing 100 µl OptiMEM 
(Gibco). Both solutions were mixed by pipetting up and down and left for 15 
minutes at room temperature; the transfection mix was added drop wise to 
cells (50-60% confluency). All siRNA duplexes were purchased from 
Microsynth with the exception of MRE11 siRNA, which was purchased from 
Dharmacon. siRNA sequences are as follow: Luciferase (siCNTL) 
(CGUACGCGGAAUACUUCGATT) (Sartori et al, 2007), CtIP 
(GCUAAAACAGGAACGAAUCTT) (Sartori et al, 2007), EXO1  
(CAAGCCUAUUCUCGUAUUUTT) (Gravel et al, 2008), and MRE11 
(GAGCAUAACUCCAUAAGUATT) (Adams et al, 2006). siRNA duplexes were 
transfected into cells using Lipofectamine RNAiMAX (Invitrogen) in two 
consecutive rounds to a final concentration of 80 nM as follows: control (80 
nM luciferase siRNA), EXO1 (40 nM EXO1 siRNA + 40 nM control siRNA), 
CtIP (40 nM CtIP siRNA + 40 nM control siRNA), or combined EXO1 and CtIP 
(40 nM EXO1 siRNA + 40 nM CtIP siRNA). Cellular analysis was typically 
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performed 72h after transfection.  
 
Antibodies and chemicals 
Mouse monoclonal antibodies used in this study included CHK1, GFP, β-
tubulin (Santa Cruz), FLAG (Sigma), γH2AX (Upstate), MRE11 (GeneTex), 
RPA2 (Calbiochem) and EXO1 (Neomarkers). Rabbit polyclonal antibodies 
included γH2AX and CHK1-pS345 (Cell Signaling), MRE11 (Novus), DNA-
PKcs-pS2056 (Abcam). Goat polyclonal antibodies included CtIP and OMNI 
(Santa Cruz). Rabbit polyclonal EXO1 antibody, F-15 was generated in rabbit 
(Clonestar, Brno, Czech Republic) and purified using a protein A-Sepharose 
column (GE Healthcare) according to the manufacturer’s instructions. The 
serum of a non-immunized rabbit (pre-immune) served as control. Rabbit 
polyclonal and mouse monoclonal CtIP antibodies (Sartori et al, 2007) were 
provided by R. Baer (Columbia University, New York, NY). Secondary 
antibodies included horseradish peroxidase (HRP)-conjugated anti-mouse 
and anti-rabbit antibodies (GE-Healthcare) and an HRP-conjugated anti-goat 
antibody (Santa Cruz). Alexa Fluor-488, -594, and -647-conjugated secondary 
antibodies for immunofluoresence were from Invitrogen. 
Camptothecin (Sigma) and AZD2281 (Olaparib, Selleck Chemicals) were 
dissolved in dymethyl sulfoxide (DMSO) at 1 mM and 10 mM stock 
concentrations, respectively. Hydroxyurea (Sigma) was dissolved in water at 1 
M stock concentration. EdU (5-ethynyl-2'-deoxyuridine) was from Invitrogen. 
The DNA-PKcs inhibitor NU7441 (Tocris Bioscience) (Leahy et al, 2004) was 
dissolved in DMSO at 5 mM stock concentration. The E. coli exonuclease 
EXOIII was from New England Biolabs. 
 
Immunofluorescence 
Cells were grown on coverslips and treated as planned. Coverslips with 
attached cells were then washed once in phosphate-buffered saline (PBS) 
and cells were either fixed in ice-cold methanol for 15 minutes on ice or in 4% 
formaldehyde (FA) (w/v) in PBS for 15 minutes at room temperature. Cells 
fixed in FA/PBS were then permeabilized using a 0.2% Triton X-100/PBS 
solution for 5 minutes at room temperature. When required, cells were pre-
Materials and Methods 
 
 90 
extracted for 5 minutes on ice in pre-extraction buffer (25 mM HEPES pH 7.4, 
50 mM NaCl, 1 mM EDTA, 3 mM MgCl2, 300 mM sucrose and 0.5% Triton X-
100) before fixation in 4% FA/PBS. Coverslips were then blocked in 3% non-
fat milk/PBS solution for 30 minutes, stained with antibodies against proteins 
of interest for at least 2 hours up to overnight, washed three times in 3% non-
fat milk/PBS, and incubated with secondary antibodies for 1 hour. Finally, 
coverslips were washed twice in PBS and once in ddH2O before mounting on 
glass slides with Vectashield (Vector Laboratories) containing DAPI and 
sealed with nail polish. Images were acquired using either a Leica confocal 
SP2 or an Olympus IX81 fluorescence microscope. 
 
Western blotting and Immunoprecipitation 
Cellular proteins were extracted using ice-cold lysis buffer (50mM Tris–HCl 
pH 7.5, 120mM NaCl, 20mM NaF, 1mM EDTA, 6mM EGTA, 15mM Na-
pyrophosphate, 0.5mM Na-orthovanadate, 1mM benzamidine, 0.1mM 
phenylmethylsulfonyl fluoride and 1% Nonidet P-40). Protein concentration 
was determined using the Bio-Rad Protein Assay Reagent (Bio-Rad). Proteins 
were separated by running whole cell extracts on SDS-polyacrylamide gels. 
Proteins were transferred to polyvinylidene difluoride (PVDF) (GE-
Healthcare), probed with appropriate antibodies and immune complexes were 
revealed using the enhanced chemiluminescence (ECL) system (GE-
Healthcare).  
EXO1 and CtIP were immunoprecipitated from 5 mg total cell extracts for 2 
hours at 4oC using the polyclonal antibody F-15 and an anti-CtIP polyclonal 
antibody respectively. The antibodies were captured using protein A 
Sepharose beads (GE-Healthcare) for 1 hour at 4oC. Beads were washed 
twice in 1 ml ice-cold TNET buffer (50 mM Tris-HCl pH 7.5, 140 mM NaCl, 1% 
Triton X-100) and twice in 1 ml ice-cold TNE buffer (50mM Tris-HCl pH 7.5, 
140 mM NaCl). Beads were heated for 10 minutes at 95oC in 2x Laemmli 
sample buffer, proteins were resolved by SDS-polyacrylamide gel 
electrophoresis and analyzed by Western blotting using appropriate 
antibodies. To exclude the possibility that the observed interactions are DNA-
mediated, ethidium bromide (Sigma) was added to all samples. 
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In vitro protein interaction 
200 ng of purified, recombinant CtIP (Sartori et al, 2007) and EXO1 (El 
Shemerly et al, 2005) were incubated either alone or together for 30 min at 4 
oC in 1 ml TNE buffer containing (50 mM Tris-HCl pH 7.5, 140 mM NaCl, 1 
mM EDTA and 10 µg/ml BSA). Proteins were immunoprecipitated with the 
antibody F-15 for 2h at 4oC and processed as described in the 
immunoprecipitation section.  
 
Exonuclease assay 
The nicked substrate was generated by incubating the pGEM-13Zf(+) plasmid 
derivative with N.BstNBI (Fischer et al, 2007) and purified by gel extraction 
(Qiagen). Exonuclease activities were assayed in a buffer containing (50 mM 
Tris-HCl pH 7.5, 50 mM NaCl, 2 mM MgCl2, 1 mM DTT and 0.1 mg/ml BSA). 
Where indicated, final concentrations of purified recombinant proteins were as 
follows: 15 nM EXO1, 15 nM CtIP and 300 nM RPA. Reactions were stopped 
by incubation in 10 mM EDTA, 0.25 % SDS and 100 µg/ml Proteinase K for 
10 min at 37° C. DNA products were separated on 0.8% agarose, stained with 
either ethidium bromide or SYBR Gold for 30 minutes and analyzed with a 
Typhoon PhosphorImager (GE Healthcare). 
Hairpin exonuclease assays were performed in 20 µl with 1 nM DNA 
substrate (annealed 3’ labeled HL1: 5’-
TCATTGCCTATCCTGACAGTCCGACACATCGGACTGTCAGGATAGGCAA
TGATCTTTTTTTTT -3’), 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 5 mM MgCl2, 
1 mM DTT and 50 ng/µl BSA at 37oC with the indicated protein concentrations 
and time-points. Reactions were terminated by addition of an equal volume of 
99% (v/v) formamide 0.1% (w/v) bromophenol blue and heating at 95°C for 5 
min. Products were resolved by electrophoresis in a 15% (w/v) polyacrylamide 
gel containing 8 M urea (acrylamide/bis-acrylamide 19:1) run in 1xTBE buffer 
(Tris/Borate/EDTA, pH 8.0) at 25 mA. Gels were dried and analyzed with a 
Typhoon PhosphorImager (GE Healthcare). 
Linearized plasmids were generated by incubating the pGEM-13Zf(+) plasmid 
derivative with either BanII (5' overhangs), HindIII (3' overhangs) or ScaI 
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(blunt ends) followed by column purification (Qiagen). Proteins used in the 
assay were mixed and incubated on ice prior to addition into reaction tubes 
containing 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 2 mM MgCl2, 1 mM DTT and 
0.1 mg/ml BSA. DNA products were separated as described above. 
 
DNA-binding assay 
Gel mobility shift assays were performed in a volume of 20 µl containing 5 nM 
of annealed 5' labeled HL1, 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM 
EDTA, 1 mM DTT, 50 ng/µl BSA. The reactions were pre-incubated with the 
corresponding proteins, 10 nM EXO1, 50 nM CtIP for 15 min at RT before 
addition of the substrate and further incubated for 60 min. After addition of 
glycerol to a final 10% concentration, separation was performed in a 6% (w/v) 
native polyacrylamide gel run in 1xTBE buffer at 25 mAmp. Gels were 
analyzed as described above. 
 
Pulse-field gel electrophoresis 
U2OS cells were mock-treated (DMSO) or camptothecin-treated for 4h. Cells 
were harvested by trypsinization and counted. Agarose plugs of 106 cells were 
prepared in a disposable plug mold (BioRad). Plugs were then incubated in 
lysis buffer (100 mM EDTA, 1% (w/v) sodium lauryl sarcosyl, 0.2% (w/v) 
sodium deoxycholate, 1mg/ml proteinase K) at 37oC for 72h. Plugs were then 
washed four times in 20 mM Tris-HCl pH 8.0, 50 mM EDTA before loading 
onto an agarose gel. Electrophoresis was performed for 23h at 14oC in 0.9% 
(w/v) Pulse Field Certified Agarose (BioRad) containing TBE buffer according 
to the conditions described in (Hanada et al, 2007) and adapted to a BioRad 
CHEF DR III apparatus.  
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The following parameters were used: 
Block I II III 
Time (h) 9 6 6 
Included angle 120 117 112 
V/cm 5.5 4.5 4.0 
Switch (s) 
(Initial-Final) 
30-18 18-9 9-5 
 
Under the electrophoresis conditions used, high molecular weight genomic 
DNA (more than several million base pairs (bp)) remains in the well, whereas 
low molecular weight DNA fragments (several Mbp to 500 kbp) migrate into 
the gel and are compacted into a single band.  The gel was then stained with 
ethidium bromide for 30 minutes and analyzed using an Alpha Innotech 
Imaging system. 
 
Colony formation assay 
72 hours after siRNA transfection, cells were either mock-treated (DMSO) or 
treated with the indicated doses of camptothecin. The drug was removed 1h 
upon treatment, cells were washed twice in pre-warmed PBS and fresh 
medium was added. Cells were cultured for additional 10–14 days at 37°C, 
5% CO2. For the PARP-inhibitor AZD2281, continuous exposure to the 
compound was ensured by a first addition 72h after the siRNA transfection, 
and a second addition 72 h after the first. Colonies were washed once with 
PBS, stained with a crystal violet/ethanol (0.5%/20%) solution, dried and 
counted by eye. All measurements were performed in triplicates. 
 
Chromosome analysis 
72h upon siRNA transfection cells were treated with camptothecin for 1h. The 
drug-containing medium was removed, cells were washed twice in pre-
warmed PBS and allowed to recover for 8h in complete medium before 
chromosome preparation. Caffeine (2 mM) was added for the last 5h to 
override the G2/M checkpoint, and colcemid (0.1 mg/ml) was added for the 
last 3h to arrest cells in metaphase. Cells were then trypsinized, centrifuged, 
re-suspended in 0.56% KCl solution and incubated for 6 minutes at room 
temperature. KCl was discarded after centrifugation and cells were re-
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suspended in a pre-fixing solution (5% acetic acid in ddH2O). Cells were then 
centrifuged and re-suspended in a fixing solution (Acetic acid: Methanol, 1:3) 
and incubated for 10 minutes at room temperature. The fixing solution was 
discarded after centrifugation and cells were re-suspended in 500 µl of the 
fixing solution. 25-30 µl of the cell suspension were spread on a glass 
microscope slide and air-dried. Coverslips were mounted using Vectashield 
with DAPI (Vector Laboratories). Images were acquired using a confocal 
Leica SP2 microscope using the 100X lens. 50 metaphase spreads were 
acquired per sample. 
 
Live cell imaging and laser micro-irradiation 
Prior to irradiation, cells were treated with 10 µM bromodeoxyuridine (BrdU) 
for 24h. DSBs were generated in the nuclei of living cells on 18 mm glass 
cover slips by micro-irradiation of arbitrarily shaped regions of interest (ROI) 
at 355 nm with 15 mW output power of the laser (Genesis 355-80, Coherent 
Inc.) (Walter et al, 2003). ROIs were irradiated for 10 consecutive times and 
identical ROIs were used in all experiments. Subsequently, fluorescence time-
lapse imaging was performed for GFP (488 nm excitation, 525-560 nm 
emission; SP5, Leica, Mannheim, Germany) using a HCX Plan-Apo 63X/NA 
1.40 oil immersion objective. During the experiments, cells were kept in 
complete growth medium under 5% CO2 at 37°C in a climate chamber. 
For fixed cell imaging, cells were grown on coverslips for 24h in the presence 
of 10 µM BrdU prior to irradiation. Coverslips were transferred to LabTek 
chamber slides (Nunc) and mounted on the microscope stage. In order to 
generate DSBs in a defined nuclear volume, laser micro-irradiation was 
performed using a MMI CELLCUT system equipped with a 355 nm UV-A laser 
(Molecular Machines & Industries) coupled to an Olympus IX71 microscope 
station. Experiments were performed using the 40X objective. The 
MMICELLTOOLS® software with MMIUVCUT® plug-in assisted the laser 
operation using an energy output of 50%. After irradiation, cells were returned 
to the incubator until the time of processing. 
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Cloning of Strep-EXO1 and Mass Spectrometric analysis 
Strep-tagged EXO1 was generated by subcloning full-length human EXO1 
cDNA in the mammalian expression vector pEXPR-IBA3 (IBA BioTAGnology), 
which allows adding a C-terminal Strep-tag to the protein of interest. EXO1 
was cloned between the BamHI and SacII restriction sites, using the primers 
5'- ATGGGAGACCGCGGGATACAGGGATTGCTACAATTTATC -3' (forward) 
and 5'- CTCGAGGGATCCCTGGAATATTGCTCTTTGAACACGG -3' 
(reverse). Constructs were verified by sequencing. HEK293T cells were 
transfected with either Strep-tagged EXO1 or with empty vector (mock), using 
Metafectene (Biontex). 72h after transfection cells were harvested in lysis 
buffer (50mM Tris–HCl pH 7.5, 120mM NaCl, 20mM NaF, 1mM EDTA, 6mM 
EGTA, 15mM Na-pyrophosphate, 0.5mM Na-orthovanadate, 1mM 
benzamidine, 0.1mM phenylmethylsulfonyl fluoride and 1% Nonidet P-40). 
20mg of the whole cell lysate from each sample (mock and Strep-tagged 
EXO1) were incubated on a rotator for 1h in 4oC with 70 µl of Strep-Tactin 
Sepharose beads (IBA BioTAGnology) equilibrated in lysis buffer. Beads were 
washed 3x with 1 ml of ice-cold lysis buffer, followed by 100 µl of 5mM D-
Desthiobiotin (IBA BioTAGnology) and incubated at 4oC for 2h with vigorous 
shaking. Beads were centrifuged, the supernatant (eluate) was transferred to 
a new tube and 100 µl of D-Desthiobiotin was added to each tube. Upon 
incubation at 4oC for 1h with vigorous shaking supernatants were recovered 
as described above and pooled. Finally, supernatants were subjected to tri-
chloracetic acid (TCA) precipitation by addition of the acid to a final 
concentration of 20% from a 50% stock (m:v in ddH2O), vortexed and 
incubated on ice for 2h. Samples were centrifuged and protein pellets were 
washed in 1 ml of 10% ice-cold TCA, vortexed and centrifuged. Pellets were 
then washed with 1 ml of ice-cold HPLC-grade acetone, centrifuged and air 
dried. Protein pellets were stored at -80oC until the time of analysis. 
Precipitated proteins were digested with trypsin. Tryptic peptides were purified 
by HPLC chromatography and peptide masses were determined using an 
LTQ Orbitrap Velos (Thermo Scientific). Proteins were identified by comparing 
the obtained spectra against the human subset of the protein sequence 
database Swiss-Prot in order to identify the proteins. 
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Abbreviations  
 
53BP1   53-binding protein 1 
ATM   Ataxia telangiectasia mutated  
ATR   Ataxia telangiectasia and Rad3 related  
BRCA1/2  Breast cancer susceptibility gene 1/2 
BRCT   BRCA1 C-terminal  
CHK1/2  Checkpoint protein 1/2  
CDK   Cyclin-dependent kinase 
CPT   Camptothecin 
CtBP   Carboxyl-terminal binding protein  
CtIP   CtBP interacting protein 
DNA-PKcs  DNA-dependent protein kinase catalytic subunit  
DSB   Double strand break  
DDR   DNA damage response 
EXO1   Exonuclease1 
FHA   Forkhead-associated  
GFP   Green fluorescent protein 
GCRs   Gross chromosomal rearrangements 
HR   Homologous recombination  
IR   Ionizing radiation  
MDC1   Mediator of DNA damage checkpoint 1  
IRIF   Ionizing radiation induced foci 
MRN   MRE11-RAD50-NBS1  
MMEJ   Microhomology-mediated end joining 
MS   Mass spectrometry  
NBS   Nijmegen breakage syndrome  
NHEJ   Non homologous end joining 
PARP   Poly(ADP-ribose) polymerase 
PIKK   Phosphoinositide-3-kinase-related protein kinase  
PNK   Polynucleotide kinase 
RNF8   Ring finger protein 8 
ROS   Reactive oxygen species 
SSB   Single-strand break 
UV   Ultraviolet light  
γH2AX  H2AX phosphorylated on Ser139 
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